Common Inflammatory Mechanisms in COVID-19 and Parkinson’s Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention

References

• Chaudhry ZL, Klenja D, Janjua N, Cami-Kobeci G, Ahmed BY. COVID-19 and Parkinson’s disease: shared inflammatory pathways under oxidative stress. Brain Sciences. 2020;10(11):807. doi:10.3390/brainsci10110807
   PubMed Web of Science ®Google Scholar
• Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–280. doi:10.1016/j.cell.2020.02.052
   PubMed Web of Science ®Google Scholar
• Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi:10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247–257. doi:10.1002/emmm.201000080
   PubMed Web of Science ®Google Scholar
• Hirano T, Murakami M. COVID-19: a new virus, but a familiar receptor and cytokine release syndrome. Immunity. 2020;52(5):731–733. doi:10.1016/j.immuni.2020.04.003
   PubMed Web of Science ®Google Scholar
• Nile SH, Nile A, Qiu J, Li L, Jia X, Kai G. COVID-19: pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine Growth Factor Rev. 2020;53:66–70. doi:10.1016/j.cytogfr.2020.05.002
   PubMed Web of Science ®Google Scholar
• de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523–534. doi:10.1038/nrmicro.2016.81
   PubMed Web of Science ®Google Scholar
• Niizuma K, Endo H, Chan PH. Oxidative stress and mitochondrial dysfunction as determinants of ischemic neuronal death and survival. J Neurochem. 2009;109(Suppl 1):133–138. doi:10.1111/j.1471-4159.2009.05897.x
   PubMedGoogle Scholar
• Hernansanz-Agustin P, Izquierdo-Alvarez A, Sanchez-Gomez FJ, et al. Acute hypoxia produces a superoxide burst in cells. Free Radic. Biol. Med. 2014;71:146–156. doi:10.1016/j.freeradbiomed.2014.03.011
   PubMed Web of Science ®Google Scholar
• Gorlach A, Dimova EY, Petry A, et al. Reactive oxygen species, nutrition, hypoxia and diseases: problems solved? Redox Biol. 2015;6:372–385. doi:10.1016/j.redox.2015.08.016
   PubMed Web of Science ®Google Scholar
• Nicholls DG. Mitochondrial calcium function and dysfunction in the central nervous system. Biochimica et Biophysica Acta. 2009;1787(11):1416–1424. doi:10.1016/j.bbabio.2009.03.010
   PubMed Web of Science ®Google Scholar
• Niizuma K, Yoshioka H, Chen H, et al. Mitochondrial and apoptotic neuronal death signaling pathways in cerebral ischemia. Biochimica et Biophysica Acta. 2010;1802(1):92–99. doi:10.1016/j.bbadis.2009.09.002
   PubMed Web of Science ®Google Scholar
• Gazewood JD, Richards DR, Clebak K. Parkinson disease: an update. Am. Fam. Physician. 2013;87(4):267–273.
   PubMed Web of Science ®Google Scholar
• Deumens R, Blokland A, Prickaerts J. Modeling Parkinson’s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol. 2002;175(2):303–317. doi:10.1006/exnr.2002.7891
   PubMed Web of Science ®Google Scholar
• Prieto-Lloret J, Donnelly DF, Rico AJ, Moratalla R, Gonzalez C, Rigual RJ. Hypoxia transduction by carotid body chemoreceptors in mice lacking dopamine D(2) receptors. J Appl Physiol (1985). 2007;103(4):1269–1275. doi:10.1152/japplphysiol.00391.2007
   PubMed Web of Science ®Google Scholar
• Andrzejewski K, Jampolska M, Zaremba M, Joniec-Maciejak I, Boguszewski PM, Kaczynska K. Respiratory pattern and phrenic and hypoglossal nerve activity during normoxia and hypoxia in 6-OHDA-induced bilateral model of Parkinson’s disease. J Physiol Sci. 2020;70(1):16. doi:10.1186/s12576-020-00743-4
   PubMed Web of Science ®Google Scholar
• Glinka YY, Youdim MBH. Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine. Eur J Pharmacol. 1995;292(3):329–332. doi:10.1016/0926-6917(95)90040-3
   PubMed Web of Science ®Google Scholar
• Blum D, Torch S, Lambeng N, et al. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Progress in Neurobiology. 2001;65(2):135–172. doi:10.1016/S0301-0082(01)00003-X
   PubMed Web of Science ®Google Scholar
• Tirmenstein MA, Hu CX, Scicchitano MS, et al. Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicology in Vitro. 2005;19(4):471–479. doi:10.1016/j.tiv.2005.01.006
   PubMed Web of Science ®Google Scholar
• Lalley PM. D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 2009;296(6):R1829–1836. doi:10.1152/ajpregu.00057.2009
   PubMed Web of Science ®Google Scholar
• Seccombe LM, Giddings HL, Rogers PG, et al. Abnormal ventilatory control in Parkinson’s disease–further evidence for non-motor dysfunction. Respiratory Physiology & Neurobiology. 2011;179(2–3):300–304. doi:10.1016/j.resp.2011.09.012
   PubMed Web of Science ®Google Scholar
• Baille G, De Jesus AM, Perez T, et al. Ventilatory Dysfunction in Parkinson’s Disease. J. Parkinsons Dis. 2016;6(3):463–471. doi:10.3233/JPD-160804
   PubMedGoogle Scholar
• Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR. Oxidative stress and Parkinson’s disease. Front Neuroanat. 2015;9:91. doi:10.3389/fnana.2015.00091
   PubMed Web of Science ®Google Scholar
• Kim GH, Kim JE, Rhie SJ, Yoon S. The Role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24(4):325–340. doi:10.5607/en.2015.24.4.325
   PubMed Web of Science ®Google Scholar
• Gong P, Deng F, Zhang W, et al. Tectorigenin attenuates the MPP(+)-induced SH-SY5Y cell damage, indicating a potential beneficial role in Parkinson’s disease by oxidative stress inhibition. Exp. Ther. Med. 2017;14(5):4431–4437. doi:10.3892/etm.2017.5049
   PubMed Web of Science ®Google Scholar
• Cassarino DS, Halvorsen EM, Swerdlow RH, et al. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappaB in cellular models of Parkinson’s disease. J Neurochem. 2000;74(4):1384–1392. doi:10.1046/j.1471-4159.2000.0741384.x
   PubMed Web of Science ®Google Scholar
• Chaudhry ZL, Ahmed BY. The role of caspases in Parkinson’s Disease pathogenesis: a brief look at the mitochondrial pathway. Austin Alzheimer’s and Parkinson’s Disease. 2014;1(3):2–5.
   Google Scholar
• Moon HE, Paek SH. Mitochondrial Dysfunction in Parkinson’s Disease. Exp Neurobiol. 2015;24(2):103–116. doi:10.5607/en.2015.24.2.103
   PubMed Web of Science ®Google Scholar
• Hunot S, Brugg B, Ricard D, et al. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 1997;94(14):7531–7536. doi:10.1073/pnas.94.14.7531
   PubMed Web of Science ®Google Scholar
• Erekat NS, Al-Jarrah MD. Association of Parkinson Disease Induction with Cardiac Upregulation of Apoptotic Mediators P53 and Active Caspase-3: an Immunohistochemistry Study. Medical Science Monitor Basic Research. 2018;24:120–126. doi:10.12659/MSMBR.910307
   PubMed Web of Science ®Google Scholar
• Wilkins LJ, Monga M, Miller AW. Defining Dysbiosis for a Cluster of Chronic Diseases. Sci Rep. 2019;9(1):12918. doi:10.1038/s41598-019-49452-y
   PubMed Web of Science ®Google Scholar
• Averina OV, Poluektova EU, Marsova MV, Danilenko VN. Biomarkers and utility of the antioxidant potential of probiotic Lactobacilli and Bifidobacteria as representatives of the human gut microbiota. Biomedicines. 2021;9(10):1340. doi:10.3390/biomedicines9101340
   PubMed Web of Science ®Google Scholar
• Wong CB, Sugahara H, Odamaki T, Xiao JZ. Different physiological properties of human-residential and non-human-residential bifidobacteria in human health. Benef Microbes. 2018;9(1):111–122. doi:10.3920/BM2017.0031
   PubMed Web of Science ®Google Scholar
• Salvetti E, O’Toole PW. When regulation challenges innovation: the case of the genus. Lactobacillus. Trends Food Sci. Technol. 2017;66:187–194. doi:10.1016/j.tifs.2017.05.009
   Web of Science ®Google Scholar
• Arboleya S, Watkins C, Stanton C, Ross RP. Gut Bifidobacteria Populations in Human Health and Aging. Front Microbiol. 2016;7:1204. doi:10.3389/fmicb.2016.01204
   PubMed Web of Science ®Google Scholar
• Stavropoulou E, Bezirtzoglou E. Probiotics in Medicine: a Long Debate. Front Immunol. 2020;11:2192. doi:10.3389/fimmu.2020.02192
   PubMed Web of Science ®Google Scholar
• Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD–implications and relevance for treatment. Int. J. Chron. Obstruct. Pulmon. Dis. 2014;9:1207–1224. doi:10.2147/COPD.S51226
   PubMed Web of Science ®Google Scholar
• Calabrese V, Santoro A, Monti D, et al. Aging and Parkinson’s Disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic. Biol. Med. 2018;115:80–91. doi:10.1016/j.freeradbiomed.2017.10.379
   PubMed Web of Science ®Google Scholar
• Senoner T, Schindler S, Stattner S, Ofner D, Troppmair J, Primavesi F. Associations of Oxidative Stress and Postoperative Outcome in Liver Surgery with an Outlook to Future Potential Therapeutic Options. Oxid. Med. Cell. Longev. 2019;2019:3950818. doi:10.1155/2019/3950818
   PubMed Web of Science ®Google Scholar
• Kovtun AS, Averina OV, Zakharevich NV, Kasianov AS, Danilenko VN. In silico Identification of Metagenomic Signature Describing Neurometabolic Potential of Normal Human Gut Microbiota. Russian Journal of Genetics. 2018;54(9):1101–1110. doi:10.1134/S1022795418090089
   Web of Science ®Google Scholar
• Averina OV, Kovtun AS, Polyakova SI, Savilova AM, Rebrikov DV, Danilenko VN. The bacterial neurometabolic signature of the gut microbiota of young children with autism spectrum disorders. J Med Microbiol. 2020a;69(4):558–571. doi:10.1099/jmm.0.001178
   PubMed Web of Science ®Google Scholar
• Benakis C, Martin-Gallausiaux C, Trezzi JP, Melton P, Liesz A, Wilmes P. The microbiome-gut-brain axis in acute and chronic brain diseases. Current Opinion in Neurobiology. 2020;61:1–9. doi:10.1016/j.conb.2019.11.009
   PubMed Web of Science ®Google Scholar
• Bercik P, Collins SM, Verdu EF. Microbes and the gut-brain axis. Neurogastroenterol Motil. 2012;24(5):405–413. doi:10.1111/j.1365-2982.2012.01906.x
   PubMed Web of Science ®Google Scholar
• Cryan JF, O’Riordan KJ, Cowan CSM, et al. The microbiota-gut-brain axis. Physiol Rev. 2019;99(4):1877–2013. doi:10.1152/physrev.00018.2018
   PubMed Web of Science ®Google Scholar
• Hill JM, Bhattacharjee S, Pogue AI, Lukiw WJ. The gastrointestinal tract microbiome and potential link to Alzheimer’s disease. Front. Neurol. 2014;5(4):43. doi:10.3389/fneur.2014.00043
   PubMedGoogle Scholar
• Klingelhoefer L, Reichmann H. Pathogenesis of Parkinson disease - the gut–brain axis and environmental factors. Nature Reviews Neurology. 2015;11(11):625–636. doi:10.1038/nrneurol.2015.197
   PubMed Web of Science ®Google Scholar
• Khan MS, Ikram M, Park JS, Park TJ, Kim MO. Gut microbiota, its role in induction of Alzheimer’s disease pathology, and possible therapeutic interventions: special focus on anthocyanins. Cells. 2020;9(4):853. doi:10.3390/cells9040853
   PubMed Web of Science ®Google Scholar
• Caputi V, Giron M. Microbiome-gut-brain axis and toll-like receptors in Parkinson’s disease. Int J Mol Sci. 2018;19(6):1689. doi:10.3390/ijms19061689
   PubMed Web of Science ®Google Scholar
• Arora K, Green M, Prakash S. The microbiome and Alzheimer’s disease: potential and limitations of prebiotic, synbiotic, and probiotic formulations. Frontiers in Bioengineering and Biotechnology. 2020;8:537847. doi:10.3389/Fbioe.2020.537847
   PubMed Web of Science ®Google Scholar
• Milyukhina IV, Karpenko MN, Timofeeva AA, Klimenko VM, Skoromec AA. The role of inflammation in the pathogenesis of Parkinson’s disease. Neurological Journal. 2013;3(18):51–55.
   Google Scholar
• Sampson TR, Debelius JW, Thron T, et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease. Cell. 2016;167(6):1469–1480.e1412. doi:10.1016/j.cell.2016.11.018
   PubMed Web of Science ®Google Scholar
• Fountain JH, Lappin SL. Physiology, Renin Angiotensin System. StatPearls. Treasure Island (FL): StatPearls Publishing LLC; 2021:29261862.
   Google Scholar
• Abiodun OA, Ola MS. Role of brain renin angiotensin system in neurodegeneration: an update. Saudi J. Biol. Sci. 2020;27(3):905–912. doi:10.1016/j.sjbs.2020.01.026
   PubMed Web of Science ®Google Scholar
• Petrie JR, Guzik TJ, Touyz RM. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Can J Cardiol. 2018;34(5):575–584. doi:10.1016/j.cjca.2017.12.005
   PubMed Web of Science ®Google Scholar
• Carbone LD, Vasan S, Prentice RL, et al. The renin-angiotensin aldosterone system and osteoporosis: findings from the women’s health initiative. Osteoporos. Int. 2019;30(10):2039–2056. doi:10.1007/s00198-019-05041-3
   PubMed Web of Science ®Google Scholar
• Scialo F, Daniele A, Amato F, et al. ACE2: the major cell entry receptor for SARS-CoV-2. Lung. 2020;198(6):867–877. doi:10.1007/s00408-020-00408-4
   PubMed Web of Science ®Google Scholar
• Kullisaar T, Songisepp E, Zilmer M. Probiotics and oxidative stress. In: Lushchak V, editor. Oxidative Stress - Environmental Induction and Dietary Antioxidants. London, UK: IntechOpen; 2012:203–222.
   Google Scholar
• Raimondi S, Amaretti A, Leonardi A, Quartieri A, Gozzoli C, Rossi M. Conjugated linoleic acid production by bifidobacteria: screening, kinetic, and composition. Biomed Res Int. 2016;2016:1–8. doi:10.1155/2016/8654317
   Web of Science ®Google Scholar
• Marsova M, Abilev S, Poluektova E, Danilenko V. A bioluminescent test system reveals valuable antioxidant properties of Lactobacillus strains from human microbiota. World J Microbiol Biotechnol. 2018;34(2):27. doi:10.1007/s11274-018-2410-2
   PubMed Web of Science ®Google Scholar
• Eslami M, Yousefi B, Kokhaei P, et al. Importance of probiotics in the prevention and treatment of colorectal cancer. J Cell Physiol. 2019;234(10):17127–17143. doi:10.1002/jcp.28473
   PubMed Web of Science ®Google Scholar
• Rinninella E, Raoul P, Cintoni M, et al. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganisms. 2019;7(1):14. doi:10.3390/microorganisms7010014
   PubMed Web of Science ®Google Scholar
• Kaźmierczak-Siedlecka K, Daca A, Fic M, van de Wetering T, Folwarski M, Makarewicz W. Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics. Gut Microbes. 2020;11(6):1518–1530. doi:10.1080/19490976.2020.1764309
   PubMed Web of Science ®Google Scholar
• Garcia-Gonzalez N, Prete R, Perugini M, Merola C, Battista N, Corsetti A. Probiotic antigenotoxic activity as a DNA bioprotective tool: a minireview with focus on endocrine disruptors. FEMS Microbiol Lett. 2020;367(3):fnaa041. doi:10.1093/femsle/fnaa041
   PubMed Web of Science ®Google Scholar
• Żółkiewicz J, Marzec A, Ruszczyński M, Feleszko W. Postbiotics - A step beyond pre- and probiotics. Nutrients. 2020;12(8):2189. doi:10.3390/nu12082189
   PubMed Web of Science ®Google Scholar
• Rad AH, Aghebati-Maleki L, Kafil HS, Abbasi A. Molecular mechanisms of postbiotics in colorectal cancer prevention and treatment. Crit. Rev. Food Sci. Nutr. 2020;61(11):1787–1803. doi:10.1080/10408398.2020.1765310
   PubMed Web of Science ®Google Scholar
• Khaled JMA. Probiotics, prebiotics, and COVID-19 infection: a review article. Saudi J. Biol. Sci. 2021;28(1):865–869. doi:10.1016/j.sjbs.2020.11.025
   PubMed Web of Science ®Google Scholar
• Seaver LC, Imlay JA. Are respiratory enzymes the primary sources of intracellular hydrogen peroxide? J Biol Chem. 2004;279(47):48742–48750. doi:10.1074/jbc.M408754200
   PubMed Web of Science ®Google Scholar
• Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biology. 2013;3(1):120144. doi:10.1098/rsob.120144
   PubMed Web of Science ®Google Scholar
• Davalli P, Marverti G, Lauriola A, D’Arca D. Targeting Oxidatively Induced DNA Damage Response in Cancer: opportunities for Novel Cancer Therapies. Oxid. Med. Cell. Longev. 2018;2018:2389523. doi:10.1155/2018/2389523
   PubMed Web of Science ®Google Scholar
• Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21(7):363–383. doi:10.1038/s41580-020-0230-3
   PubMed Web of Science ®Google Scholar
• Vona R, Pallotta L, Cappelletti M, Severi C, Matarrese P. The Impact of Oxidative Stress in Human Pathology: focus on Gastrointestinal Disorders. Antioxidants. 2021;10(2):201. doi:10.3390/antiox10020201
   Web of Science ®Google Scholar
• Imlay JA. Pathways of oxidative damage. Annual Review of Microbiology. 2003;57:395–418. doi:10.1146/annurev.micro.57.030502.090938
   PubMed Web of Science ®Google Scholar
• Hardin SC, Larue CT, Oh MH, Jain V, Huber SC. Coupling oxidative signals to protein phosphorylation via methionine oxidation in Arabidopsis. Biochemical Journal. 2009;422(2):305–312. doi:10.1042/BJ20090764
   PubMedGoogle Scholar
• Zuo L, Prather ER, Stetskiv M, et al. Inflammaging and Oxidative Stress in Human Diseases: from Molecular Mechanisms to Novel Treatments. Int J Mol Sci. 2019;20(18):4472. doi:10.3390/ijms20184472
   PubMed Web of Science ®Google Scholar
• Black CN, Bot M, Scheffer PG, Cuijpers P, Penninx BW. Is depression associated with increased oxidative stress? A systematic review and meta-analysis. Psychoneuroendocrinology. 2015;51:164–175. doi:10.1016/j.psyneuen.2014.09.025
   PubMed Web of Science ®Google Scholar
• Prasad KN. Oxidative Stress, Pro-Inflammatory Cytokines, and Antioxidants Regulate Expression Levels of MicroRNAs in Parkinson’s Disease. Curr Aging Sci. 2017;10(3):177–184. doi:10.2174/1874609810666170102144233
   PubMedGoogle Scholar
• Lindqvist D, Dhabhar FS, James SJ, et al. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology. 2017;76:197–205. doi:10.1016/j.psyneuen.2016.11.031
   PubMed Web of Science ®Google Scholar
• Fedoce ADG, Ferreira F, Bota RG, Bonet-Costa V, Sun PY, Davies KJA. The role of oxidative stress in anxiety disorder: cause or consequence? Free Radic. Res. 2018;52(7):737–750. doi:10.1080/10715762.2018.1475733
   PubMed Web of Science ®Google Scholar
• Galecki P, Talarowska M. Inflammatory theory of depression. Psychiatr. Pol. 2018;52(3):437–447. doi:10.12740/PP/76863
   PubMed Web of Science ®Google Scholar
• Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019;16(1):53. doi:10.1186/s12974-019-1434-3
   PubMed Web of Science ®Google Scholar
• Segal AW. How neutrophils kill microbes. Annu. Rev. Immunol. 2005;23:197–223. doi:10.1146/annurev.immunol.23.021704.115653
   PubMed Web of Science ®Google Scholar
• Gems D, Partridge L. Stress-response hormesis and aging: “that which does not kill us makes us stronger”. Cell Metab. 2008;7(3):200–203. doi:10.1016/j.cmet.2008.01.001
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S. Inflammation During Virus Infection: swings and Roundabouts. In: Bramhachari PV, editor. Dynamics of Immune Activation in Viral Diseases. Singapore: Springer Singapore; 2020:43–59.
   Google Scholar
• Rouse BT. Virus-induced immunopathology. Adv. Virus Res. 1996;47:353–376. doi:10.1016/s0065-3527(08)60739-3
   PubMed Web of Science ®Google Scholar
• Rouse BT, Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 2010;10(7):514–526. doi:10.1038/nri2802
   PubMed Web of Science ®Google Scholar
• Allen IC, Scull MA, Moore CB, et al. The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity. 2009;30(4):556–565. doi:10.1016/j.immuni.2009.02.005
   PubMed Web of Science ®Google Scholar
• Thomas PG, Dash P, Aldridge JR, et al. The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity. 2009;30(4):566–575. doi:10.1016/j.immuni.2009.02.006
   PubMed Web of Science ®Google Scholar
• Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiology and Molecular Biology Reviews. 2012;76(1):16–32. doi:10.1128/MMBR.05015-11
   PubMed Web of Science ®Google Scholar
• Tarlinton RE, Martynova E, Rizvanov AA, Khaiboullina S, Verma S. Role of viruses in the pathogenesis of multiple sclerosis. Viruses. 2020;12(6):643. doi:10.3390/v12060643
   PubMed Web of Science ®Google Scholar
• Paz SPC, Branco L, Pereira MA, Spessotto C, Fragoso YD. Systematic review of the published data on the worldwide prevalence of John Cunningham virus in patients with multiple sclerosis and neuromyelitis optica. Epidemiol Health. 2018;40:e2018001. doi:10.4178/epih.e2018001
   PubMed Web of Science ®Google Scholar
• Barzon L. Ongoing and emerging arbovirus threats in Europe. J. Clin. Virol. 2018;107:38–47. doi:10.1016/j.jcv.2018.08.007
   PubMed Web of Science ®Google Scholar
• Delbue S, Tadeo CS, Elia F, Ferrante P. JC virus replication at the first symptoms of multiple sclerosis: a case report. Intervirology. 2015;58(5):278–282. doi:10.1159/000441473
   PubMed Web of Science ®Google Scholar
• Mangiardi M, Crawford DK, Xia X, et al. An animal model of cortical and callosal pathology in multiple sclerosis. Brain Pathol. 2011;21(3):263–278. doi:10.1111/j.1750-3639.2010.00444.x
   PubMed Web of Science ®Google Scholar
• Leibovitch EC, Jacobson S. Evidence linking HHV-6 with multiple sclerosis: an update. Curr Opin Virol. 2014;9:127–133. doi:10.1016/j.coviro.2014.09.016
   PubMed Web of Science ®Google Scholar
• Pormohammad A, Azimi T, Falah F, Faghihloo E. Relationship of human herpes virus 6 and multiple sclerosis: a systematic review and meta-analysis. J Cell Physiol. 2018;233(4):2850–2862. doi:10.1002/jcp.26000
   PubMed Web of Science ®Google Scholar
• Akinsoji EO, Leibovitch E, Billioux BJ, et al. HHV‐6 and hippocampal volume in patients with mesial temporal sclerosis. Ann Clin Transl Neur. 2020;7(9):1674–1680. doi:10.1002/acn3.51152
   PubMed Web of Science ®Google Scholar
• Bu X-L, Wang X, Xiang Y, et al. The association between infectious burden and Parkinson’s disease: a case-control study. Parkinsonism Relat Disord. 2015;21(8):877–881. doi:10.1016/j.parkreldis.2015.05.015
   PubMed Web of Science ®Google Scholar
• Tan JSY, Chao YX, Rotzschke O, Tan EK. New Insights into Immune-Mediated Mechanisms in Parkinson’s Disease. Int J Mol Sci. 2020;21(23):9302. doi:10.3390/ijms21239302
   PubMed Web of Science ®Google Scholar
• Braak H, de Vos RAI, Bohl J, Del Tredici K. Gastric α-synuclein immunoreactive inclusions in Meissner’s and Auerbach’s plexuses in cases staged for Parkinson’s disease-related brain pathology. Neurosci Lett. 2006;396(1):67–72. doi:10.1016/j.neulet.2005.11.012
   PubMed Web of Science ®Google Scholar
• Svensson E, Horváth-Puhó E, Thomsen RW, et al. Vagotomy and subsequent risk of Parkinson’s disease. Ann Neurol. 2015;78(4):522–529. doi:10.1002/ana.24448
   PubMed Web of Science ®Google Scholar
• Alifirova VM, Zhukova NG, Zhukova IA, et al. Correlation between emotional-affective disorders and gut microbiota composition in patients with Parkinson’s disease. Annals of the Russian Academy of Medical Sciences. 2016;71(6):427–435. doi:10.15690/vramn734
   Google Scholar
• Mertsalmi TH, Aho VTE, Pereira PAB, et al. More than constipation - bowel symptoms in Parkinson’s disease and their connection to gut microbiota. Eur. J. Neurol. 2017;24(11):1375–1383. doi:10.1111/ene.13398
   PubMed Web of Science ®Google Scholar
• Lassmann H. Multiple sclerosis pathology. Cold Spring Harb. Perspect. Med. 2018;8(3):a028936. doi:10.1101/cshperspect.a028936
   PubMed Web of Science ®Google Scholar
• Wang H, Wang K, Xu W, et al. Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase. J Neurochem. 2012;122(1):19–23. doi:10.1111/j.1471-4159.2012.07749.x
   PubMed Web of Science ®Google Scholar
• Williams-Gray CH, Wijeyekoon R, Yarnall AJ, et al. Serum immune markers and disease progression in an incident Parkinson’s disease cohort (ICICLE-PD). Mov Disord. 2016;31(7):995–1003. doi:10.1002/mds.26563
   PubMed Web of Science ®Google Scholar
• Wilen CB, Trypsteen W, Van Cleemput J, Snippenberg W, Gerlo S, Vandekerckhove L. On the whereabouts of SARS-CoV-2 in the human body: a systematic review. PLoS Path. 2020;16(10):e1009037. doi:10.1371/journal.ppat.1009037
   PubMed Web of Science ®Google Scholar
• Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res. 2020;285:198018. doi:10.1016/j.virusres.2020.198018
   PubMed Web of Science ®Google Scholar
• Azkur AK, Akdis M, Azkur D, et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy. 2020;75(7):1564–1581. doi:10.1111/all.14364
   PubMed Web of Science ®Google Scholar
• Khatiwada S, Subedi A. Lung microbiome and coronavirus disease 2019 (COVID-19): possible link and implications. Hum Microb J. 2020;17:100073. doi:10.1016/j.humic.2020.100073
   PubMedGoogle Scholar
• Demyanovskaya EG, Kryzhanovsky SM, Vasiliev AS, Shmyrev VI. Neurological aspects of COVID-19. Patient management tactics by a neurologist, taking into account the epidemiological situation. Lechashchiy Vrach. 2021;1(2):54–60. doi:10.26295/os.2021.63.96.011
   Google Scholar
• Ni Y, Yang X, Zheng L, et al. Lactobacillus and Bifidobacterium improves physiological function and cognitive ability in aged mice by the regulation of gut microbiota. Mol. Nutr. Food Res. 2019;63(22):1900603. doi:10.1002/mnfr.201900603
   PubMed Web of Science ®Google Scholar
• Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–1263. doi:10.1126/science.abb2507
   PubMed Web of Science ®Google Scholar
• Li WH, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450–454. doi:10.1038/nature02145
   PubMed Web of Science ®Google Scholar
• Li F, Li WH, Farzan M, Harrison SC. Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science. 2005;309(5742):1864–1868. doi:10.1126/science.1116480
   PubMed Web of Science ®Google Scholar
• Song WF, Gui M, Wang XQ, Xiang Y. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLoS Path. 2018;14(8):e1007236. doi:10.1371/journal.ppat.1007236
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM. Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010;128(1):119–128. doi:10.1016/j.pharmthera.2010.06.003
   PubMed Web of Science ®Google Scholar
• Grant MC, Geoghegan L, Arbyn M, et al. The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): a systematic review and meta-analysis of 148 studies from 9 countries. PLoS One. 2020;15(6):e0234765. doi:10.1371/journal.pone.0234765
   PubMed Web of Science ®Google Scholar
• Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603–1605. doi:10.1016/S0140-6736(21)00869-2
   PubMed Web of Science ®Google Scholar
• Wang CC, Prather KA, Sznitman J, et al. Airborne transmission of respiratory viruses. Science. 2021;373(6558):eabd9149. doi:10.1126/science.abd9149
   PubMed Web of Science ®Google Scholar
• Tsai PH, Lai WY, Lin YY, et al. Clinical manifestation and disease progression in COVID-19 infection. J Chin Med Assoc. 2021;84(1):3–8. doi:10.1097/JCMA.0000000000000463
   PubMed Web of Science ®Google Scholar
• Harrison AG, Lin T, Wang P. Mechanisms of SARS-CoV-2 Transmission and Pathogenesis. Trends Immunol. 2020;41(12):1100–1115. doi:10.1016/j.it.2020.10.004
   PubMed Web of Science ®Google Scholar
• Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur. J. Intern. Med. 2020;76:14–20. doi:10.1016/j.ejim.2020.04.037
   PubMed Web of Science ®Google Scholar
• Letko M, Marzi A, Munster V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nature Microbiology. 2020;5(4):562–569. doi:10.1038/s41564-020-0688-y
   PubMed Web of Science ®Google Scholar
• Eketunde AO, Mellacheruvu SP, Oreoluwa PA. Review of Postmortem Findings in Patients With COVID-19. Cureus. 2020;12(7):e9438. doi:10.7759/cureus.9438
   PubMed Web of Science ®Google Scholar
• da Rosa Mesquita R, Francelino Silva Junior LC, Santos Santana FM, et al. Clinical manifestations of COVID-19 in the general population: systematic review. Wien Klin Wochenschr. 2021;133(7–8):377–382. doi:10.1007/s00508-020-01760-4
   PubMed Web of Science ®Google Scholar
• Marik PE, Iglesias J, Varon J, Kory P. A scoping review of the pathophysiology of COVID-19. Int J Immunopathol Pharmacol. 2021;35:20587384211048026. doi:10.1177/20587384211048026
   Web of Science ®Google Scholar
• Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–555. doi:10.1002/jmv.25728
   PubMed Web of Science ®Google Scholar
• Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 Virus Targeting the CNS: tissue Distribution, Host-Virus Interaction, and Proposed Neurotropic Mechanisms. ACS Chem Neurosci. 2020;11(7):995–998. doi:10.1021/acschemneuro.0c00122
   PubMed Web of Science ®Google Scholar
• Yavarpour-Bali H, Ghasemi-Kasman M. Update on neurological manifestations of COVID-19. Life Sciences. 2020;257:118063. doi:10.1016/j.lfs.2020.118063
   PubMed Web of Science ®Google Scholar
• Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020;16(11):636–644. doi:10.1038/s41582-020-0398-3
   PubMed Web of Science ®Google Scholar
• Gu J, Han B, Wang J. COVID-19: gastrointestinal Manifestations and Potential Fecal-Oral Transmission. Gastroenterology. 2020;158(6):1518–1519. doi:10.1053/j.gastro.2020.02.054
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int. J. Antimicrob. Agents. 2020;55(5):105954. doi:10.1016/j.ijantimicag.2020.105954
   PubMed Web of Science ®Google Scholar
• Gomez-Rial J, Rivero-Calle I, Salas A, Martinon-Torres F. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: implications for Therapy. Infect Drug Resist. 2020;13:2485–2493. doi:10.2147/IDR.S258639
   PubMed Web of Science ®Google Scholar
• Soy M, Keser G, Atagunduz P, Tabak F, Atagunduz I, Kayhan S. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin. Rheumatol. 2020;39(7):2085–2094. doi:10.1007/s10067-020-05190-5
   PubMed Web of Science ®Google Scholar
• Quirch M, Lee J, Rehman S. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: review. J. Med. Internet Res. 2020;22(8):e20193. doi:10.2196/20193
   PubMed Web of Science ®Google Scholar
• Wiese OJ, Allwood BW, Zemlin AE. COVID-19 and the renin-angiotensin system (RAS): a spark that sets the forest alight? Med. Hypotheses. 2020;144:110231. doi:10.1016/j.mehy.2020.110231
   PubMed Web of Science ®Google Scholar
• Bhaskar S, Sinha A, Banach M, et al. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: the REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. doi:10.3389/fimmu.2020.01648
   PubMed Web of Science ®Google Scholar
• Beltran-Garcia J, Osca-Verdegal R, Pallardo FV, et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: the Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants. 2020;9(10):936. doi:10.3390/antiox9100936
   Web of Science ®Google Scholar
• Cecchini R, Cecchini AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med. Hypotheses. 2020;143:110102. doi:10.1016/j.mehy.2020.110102
   PubMed Web of Science ®Google Scholar
• Delgado-Roche L, Mesta F. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection. Arch Med Res. 2020;51(5):384–387. doi:10.1016/j.arcmed.2020.04.019
   PubMed Web of Science ®Google Scholar
• Gan R, Rosoman NP, Henshaw DJE, Noble EP, Georgius P, Sommerfeld N. COVID-19 as a viral functional ACE2 deficiency disorder with ACE2 related multi-organ disease. Med. Hypotheses. 2020;144:110024. doi:10.1016/j.mehy.2020.110024
   PubMed Web of Science ®Google Scholar
• Wei Y, Sowers JR, Nistala R, et al. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem. 2006;281(46):35137–35146. doi:10.1074/jbc.M601320200
   PubMed Web of Science ®Google Scholar
• Zablocki D, Sadoshima J. Angiotensin II and oxidative stress in the failing heart. Antioxid Redox Signal. 2013;19(10):1095–1109. doi:10.1089/ars.2012.4588
   PubMed Web of Science ®Google Scholar
• Dikalov SI, Nazarewicz RR, Angiotensin I. I-induced production of mitochondrial reactive oxygen species: potential mechanisms and relevance for cardiovascular disease. Antioxid Redox Signal. 2013;19(10):1085–1094. doi:10.1089/ars.2012.4604
   PubMed Web of Science ®Google Scholar
• Rincon J, Correia D, Arcaya JL, et al. Role of Angiotensin II type 1 receptor on renal NAD(P)H oxidase, oxidative stress and inflammation in nitric oxide inhibition induced-hypertension. Life Sciences. 2015;124:81–90. doi:10.1016/j.lfs.2015.01.005
   PubMed Web of Science ®Google Scholar
• Valente AJ, Yoshida T, Murthy SN, et al. Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18. American Journal of Physiology Heart and Circulatory Physiology. 2012;303(3):H282–296. doi:10.1152/ajpheart.00231.2012
   PubMed Web of Science ®Google Scholar
• Oudit GY, Kassiri Z, Patel MP, et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc. Res. 2007;75(1):29–39. doi:10.1016/j.cardiores.2007.04.007
   PubMed Web of Science ®Google Scholar
• Sawalha AH, Zhao M, Coit P, Lu Q. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients. Clin Immunol. 2020;215:108410. doi:10.1016/j.clim.2020.108410
   PubMed Web of Science ®Google Scholar
• Violi F, Oliva A, Cangemi R, et al. Nox2 activation in Covid-19. Redox Biol. 2020;36:101655. doi:10.1016/j.redox.2020.101655
   PubMed Web of Science ®Google Scholar
• Barnes BJ, Adrover JM, Baxter-Stoltzfus A, et al. Targeting potential drivers of COVID-19: neutrophil extracellular traps. Journal of Experimental Medicine. 2020;217(6):e20200652. doi:10.1084/jem.20200652
   PubMed Web of Science ®Google Scholar
• Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130(5):2620–2629. doi:10.1172/JCI137244
   PubMed Web of Science ®Google Scholar
• Gong J, Dong H, Xia Q, et al. Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia. medRxiv. 2020;1:202. doi:10.1101/2020.02.25.20025643
   Google Scholar
• Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. doi:10.1093/cid/ciaa248
   PubMed Web of Science ®Google Scholar
• Yang Y, Shen C, Li J, et al. Exuberant elevation of IP-10, MCP-3 and IL-1ra during SARS-CoV-2 infection is associated with disease severity and fatal outcome. medRxiv. 2020;1:20029975. doi:10.1101/2020.03.02.20029975
   Google Scholar
• Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0
   PubMed Web of Science ®Google Scholar
• Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46(5):846–848. doi:10.1007/s00134-020-05991-x
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine. 2020;180(7):934–943. doi:10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Wu D, Yang XO. TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor Fedratinib. J Microbiol Immunol Infect. 2020;53(3):368–370. doi:10.1016/j.jmii.2020.03.005
   PubMedGoogle Scholar
• Zhang W, Zhao Y, Zhang F, et al. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the Perspectives of clinical immunologists from China. Clin Immunol. 2020;214:108393. doi:10.1016/j.clim.2020.108393
   PubMed Web of Science ®Google Scholar
• Merad M, Martin JC. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat. Rev. Immunol. 2020;20(6):355–362. doi:10.1038/s41577-020-0331-4
   PubMed Web of Science ®Google Scholar
• Wang JZ, Zhang RY, Bai J. An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients. Int J Cardiol. 2020;312:137–138. doi:10.1016/j.ijcard.2020.04.009
   PubMed Web of Science ®Google Scholar
• Nagar H, Piao S, Kim C-S. Role of Mitochondrial Oxidative Stress in Sepsis. Acute Crit Care. 2018;33(2):65–72. doi:10.4266/acc.2018.00157
   PubMed Web of Science ®Google Scholar
• Galley HF. Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth. 2011;107(1):57–64. doi:10.1093/bja/aer093
   PubMed Web of Science ®Google Scholar
• Alexoudi A, Alexoudi I, Gatzonis S. Parkinson’s disease pathogenesis, evolution and alternative pathways: a review. Rev. Neurol. (Paris). 2018;174(10):699–704. doi:10.1016/j.neurol.2017.12.003
   PubMed Web of Science ®Google Scholar
• Reich SG, Savitt JM. Parkinson’s disease. Med. Clin. North Am. 2019;103(2):337–350. doi:10.1016/j.mcna.2018.10.014
   PubMed Web of Science ®Google Scholar
• Dorsey ER, Sherer T, Okun MS, et al. The emerging evidence of the Parkinson pandemic. J. Parkinsons Dis. 2018;8(1):3–8. doi:10.3233/jpd-181474
   Google Scholar
• Feigin VL, Nichols E, Alam T, et al. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the global burden of disease study 2016. The Lancet Neurology. 2019;18(5):459–480. doi:10.1016/s1474-4422(18)30499-x
   PubMed Web of Science ®Google Scholar
• Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 2017;9(7):a028035. doi:10.1101/cshperspect.a028035
   PubMed Web of Science ®Google Scholar
• Illarioshkin SN, Klyushnikov SA, Vigont VA, Seliverstov YA, Kaznacheyeva EV. Molecular pathogenesis in Huntington’s disease. Biochemistry. 2018;83(9):1030–1039. doi:10.1134/s0006297918090043
   PubMed Web of Science ®Google Scholar
• Kotagal V, Bohnen NI, Müller MLTM, Frey KA, Albin RL. Cerebral amyloid burden and Hoehn and Yahr stage 3 scoring in Parkinson disease. J. Parkinsons Dis. 2017;7(1):143–147. doi:10.3233/jpd-160985
   PubMedGoogle Scholar
• Lubomski M, Tan AH, Lim S-Y, Holmes AJ, Davis RL, Sue CM. Parkinson’s disease and the gastrointestinal microbiome. J. Neurol. 2019;267(9):2507–2523. doi:10.1007/s00415-019-09320-1
   PubMed Web of Science ®Google Scholar
• Kontis V, Bennett JE, Mathers CD, Li G, Foreman K, Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. The Lancet. 2017;389(10076):1323–1335. doi:10.1016/S0140-6736(16)32381-9
   PubMed Web of Science ®Google Scholar
• Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson’s disease: a unifying theory. Ageing Research Reviews. 2021;70:101396. doi:10.1016/j.arr.2021.101396
   PubMed Web of Science ®Google Scholar
• Langston JW. Current theories on the cause of Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry. 1989;Suppl:13–17. doi:10.1136/jnnp.52.suppl.13
   PubMedGoogle Scholar
• Kalia LV, Lang AE. Parkinson’s disease. The Lancet. 2015;386(9996):896–912. doi:10.1016/S0140-6736(14)61393-3
   PubMed Web of Science ®Google Scholar
• Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P. Triggers, Facilitators, and Aggravators: redefining Parkinson’s Disease Pathogenesis. Trends in Neurosciences. 2019;42(1):4–13. doi:10.1016/j.tins.2018.09.007
   PubMed Web of Science ®Google Scholar
• Kempster PA, Hurwitz B, Lees AJ. James Parkinson’s Chimera: syndrome or disease? J R Coll Physicians Edinb. 2017;47(2):190–195. doi:10.4997/JRCPE.2017.220
   PubMedGoogle Scholar
• Obeso JA, Stamelou M, Goetz CG, et al. Past, present, and future of Parkinson’s disease: a special essay on the 200th Anniversary of the Shaking Palsy. Mov Disord. 2017;32(9):1264–1310. doi:10.1002/mds.27115
   PubMed Web of Science ®Google Scholar
• Titova N, Padmakumar C, Lewis SJG, Chaudhuri KR. Parkinson’s: a syndrome rather than a disease? J Neural Transm (Vienna). 2017;124(8):907–914. doi:10.1007/s00702-016-1667-6
   PubMed Web of Science ®Google Scholar
• Burke RE, Dauer WT, Vonsattel JP. A critical evaluation of the Braak staging scheme for Parkinson’s disease. Ann Neurol. 2008;64(5):485–491. doi:10.1002/ana.21541
   PubMed Web of Science ®Google Scholar
• Cardoso SM, Empadinhas N. The Microbiome-Mitochondria Dance in Prodromal Parkinson’s Disease. Front. Physiol. 2018;9:471. doi:10.3389/fphys.2018.00471
   PubMed Web of Science ®Google Scholar
• Engen PA, Dodiya HB, Naqib A, et al. The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy. J. Parkinsons Dis. 2017;7(2):331–346. doi:10.3233/JPD-160991
   PubMedGoogle Scholar
• Houser MC, Tansey MG. The gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis? NPJ Parkinsons Dis. 2017;3:3. doi:10.1038/s41531-016-0002-0
   PubMed Web of Science ®Google Scholar
• Matheoud D, Cannon T, Voisin A, et al. Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1(-/-) mice. Nature. 2019;571(7766):565–569. doi:10.1038/s41586-019-1405-y
   PubMed Web of Science ®Google Scholar
• Gray MT, Woulfe JM. Striatal blood-brain barrier permeability in Parkinson’s disease. J. Cereb. Blood Flow Metab. 2015;35(5):747–750. doi:10.1038/jcbfm.2015.32
   PubMed Web of Science ®Google Scholar
• Campos-Acuna J, Elgueta D, Pacheco R. T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson’s Disease. Front Immunol. 2019;10:239. doi:10.3389/fimmu.2019.00239
   PubMed Web of Science ®Google Scholar
• Peralta Ramos JM, Iribarren P, Bousset L, Melki R, Baekelandt V. Peripheral Inflammation Regulates CNS Immune Surveillance Through the Recruitment of Inflammatory Monocytes Upon Systemic alpha-Synuclein Administration. Front Immunol. 2019;10:80. doi:10.3389/fimmu.2019.00080
   PubMed Web of Science ®Google Scholar
• Sweeney MD, Sagare AP, Zlokovic BV. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14(3):133–150. doi:10.1038/nrneurol.2017.188
   PubMed Web of Science ®Google Scholar
• Unger MM, Spiegel J, Dillmann KU, et al. Short chain fatty acids and gut microbiota differ between patients with Parkinson’s disease and age-matched controls. Parkinsonism Relat Disord. 2016;32:66–72. doi:10.1016/j.parkreldis.2016.08.019
   PubMed Web of Science ®Google Scholar
• Devos D, Lebouvier T, Lardeux B, et al. Colonic inflammation in Parkinson’s disease. Neurobiol Dis. 2013;50:42–48. doi:10.1016/j.nbd.2012.09.007
   PubMed Web of Science ®Google Scholar
• Harms AS, Thome AD, Yan Z, et al. Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol. 2018;300:179–187. doi:10.1016/j.expneurol.2017.11.010
   PubMed Web of Science ®Google Scholar
• Palm NW, de Zoete MR, Cullen TW, et al. Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease. Cell. 2014;158(5):1000–1010. doi:10.1016/j.cell.2014.08.006
   PubMed Web of Science ®Google Scholar
• Fitzpatrick Z, Frazer G, Ferro A, et al. Gut-educated IgA plasma cells defend the meningeal venous sinuses. Nature. 2020;587(7834):472–476. doi:10.1038/s41586-020-2886-4
   PubMed Web of Science ®Google Scholar
• Probstel AK, Zhou X, Baumann R, et al. Gut microbiota-specific IgA(+) B cells traffic to the CNS in active multiple sclerosis. Sci Immunol. 2020;5(53):eabc7191. doi:10.1126/sciimmunol.abc7191
   PubMed Web of Science ®Google Scholar
• Shalapour S, Lin XJ, Bastian IN, et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature. 2017;551(7680):340–345. doi:10.1038/nature24302
   PubMed Web of Science ®Google Scholar
• Rojas OL, Probstel AK, Porfilio EA, et al. Recirculating Intestinal IgA-Producing Cells Regulate Neuroinflammation via IL-10. Cell. 2019;176(3):610–624 e618. doi:10.1016/j.cell.2018.11.035
   PubMed Web of Science ®Google Scholar
• Buscarinu MC, Cerasoli B, Annibali V, et al. Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: a pilot study. Mult. Scler. 2017;23(3):442–446. doi:10.1177/1352458516652498
   PubMed Web of Science ®Google Scholar
• Mirabito Colafella KM, Bovée DM, Danser AHJ. The renin-angiotensin-aldosterone system and its therapeutic targets. Exp Eye Res. 2019;186:107680. doi:10.1016/j.exer.2019.05.020
   PubMed Web of Science ®Google Scholar
• Wanka H, Staar D, Lutze P, et al. Anti-necrotic and cardioprotective effects of a cytosolic renin isoform under ischemia-related conditions. J. Mol. Med. 2015;94(1):61–69. doi:10.1007/s00109-015-1321-z
   PubMed Web of Science ®Google Scholar
• Patel S, Rauf A, Khan H, Abu-Izneid T. Renin-angiotensin-aldosterone (RAAS): the ubiquitous system for homeostasis and pathologies. Biomed. Pharmacother. 2017;94:317–325. doi:10.1016/j.biopha.2017.07.091
   PubMed Web of Science ®Google Scholar
• Peach MJ, Dostal DE. The angiotensin II receptor and the actions of angiotensin II. J. Cardiovasc. Pharmacol. 1990;16(4):25–30. doi:10.1097/00005344-199016004-00007
   Google Scholar
• Durante A, Peretto G, Laricchia A, et al. Role of the renin-angiotensin-aldosterone system in the pathogenesis of atherosclerosis. Curr. Pharm. Des. 2012;18(7):981–1004. doi:10.2174/138161212799436467
   PubMed Web of Science ®Google Scholar
• Hamming I, Cooper ME, Haagmans BL, et al. The emerging role of ACE2 in physiology and disease. The Journal of Pathology. 2007;212(1):1–11. doi:10.1002/path.2162
   PubMed Web of Science ®Google Scholar
• Rodriguez-Perez AI, Garrido-Gil P, Pedrosa MA, et al. Angiotensin type 2 receptors: role in aging and neuroinflammation in the substantia nigra. Brain, Behav., Immun. 2020;87:256–271. doi:10.1016/j.bbi.2019.12.011
   PubMed Web of Science ®Google Scholar
• Gathiram P, Moodley J. The role of the renin-angiotensin-aldosterone system in preeclampsia: a review. Curr. Hypertens. Rep. 2020;22(11):89. doi:10.1007/s11906-020-01098-2
   PubMed Web of Science ®Google Scholar
• Mascolo A, Sessa M, Scavone C, et al. New and old roles of the peripheral and brain renin–angiotensin–aldosterone system (RAAS): focus on cardiovascular and neurological diseases. Int J Cardiol. 2017;227:734–742. doi:10.1016/j.ijcard.2016.10.069
   PubMed Web of Science ®Google Scholar
• Panariello F, Cellini L, Speciani M, De Ronchi D, Atti AR. How does SARS-CoV-2 affect the central nervous system? A working hypothesis. Front Psychiatry. 2020;11:582345. doi:10.3389/fpsyt.2020.582345
   PubMed Web of Science ®Google Scholar
• Labandeira-García JL, Garrido-Gil P, Rodriguez-Pallares J, Valenzuela R, Borrajo A, Rodriguez-Perez AI. Brain renin-angiotensin system and dopaminergic cell vulnerability. Front Neuroanat. 2014;8(8):67. doi:10.3389/fnana.2014.00067
   PubMedGoogle Scholar
• Kobiec T, Otero-Losada M, Chevalier G, et al. The renin–angiotensin system modulates dopaminergic neurotransmission: a new player on the scene. Front. Synaptic Neurosci. 2021;13:16. doi:10.3389/fnsyn.2021.638519
   Web of Science ®Google Scholar
• Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities – role of gut microbiota dysbiosis. Ageing Research Reviews. 2020;62:101123. doi:10.1016/j.arr.2020.101123
   PubMed Web of Science ®Google Scholar
• Ames MK, Atkins CE, Pitt B. The renin‐angiotensin‐aldosterone system and its suppression. J. Vet. Intern. Med. 2019;33(2):363–382. doi:10.1111/jvim.15454
   PubMed Web of Science ®Google Scholar
• Yang T, Xu C. Physiology and Pathophysiology of the Intrarenal Renin-Angiotensin System: an Update. J Am Soc Nephrol. 2017;28(4):1040–1049. doi:10.1681/ASN.2016070734
   PubMed Web of Science ®Google Scholar
• Alexandre J, Cracowski J-L, Richard V, Bouhanick B. Renin-angiotensin-aldosterone system and COVID-19 infection. Ann Endocrinol. 2020;81(2–3):63–67. doi:10.1016/j.ando.2020.04.005
   PubMed Web of Science ®Google Scholar
• Tseng YH, Yang RC, Lu TS. Two hits to the renin‐angiotensin system may play a key role in severe COVID‐19. Kaohsiung J. Med. Sci. 2020;36(6):389–392. doi:10.1002/kjm2.12237
   PubMed Web of Science ®Google Scholar
• Coto E, Avanzas P, Gómez J. The renin–angiotensin–aldosterone system and coronavirus disease 2019. European Cardiology Review. 2021;16:e07. doi:10.15420/ecr.2020.30
   PubMed Web of Science ®Google Scholar
• Oudit GY, Kassiri Z, Jiang C, et al. SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur. J. Clin. Invest. 2009;39(7):618–625. doi:10.1111/j.1365-2362.2009.02153.x
   PubMed Web of Science ®Google Scholar
• Shang J, Wan Y, Luo C, et al. Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America. 2020;117(21):11727–11734. doi:10.1073/pnas.2003138117
   PubMed Web of Science ®Google Scholar
• South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol-Heart C. 2020;318(5):1084–1090. doi:10.1152/ajpheart.00217.2020
   PubMed Web of Science ®Google Scholar
• Datta PK, Liu F, Fischer T, Rappaport J, Qin X. SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics. 2020;10(16):7448–7464. doi:10.7150/thno.48076
   PubMed Web of Science ®Google Scholar
• Kumar BK, Sekhar KV. Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19. Bioorg. Chem. 2020;104:104269. doi:10.1016/j.bioorg.2020.104269
   PubMed Web of Science ®Google Scholar
• Kuba K, Imai Y, Penninger JM. Angiotensin-converting enzyme 2 in lung diseases. Curr Opin Pharmacol. 2006;6(3):271–276. doi:10.1016/j.coph.2006.03.001
   PubMed Web of Science ®Google Scholar
• Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA-J Am Med Assoc. 2020;323(16):1612–1614. doi:10.1001/jama.2020.4326
   PubMed Web of Science ®Google Scholar
• Mertens B, Vanderheyden P, Michotte Y, Sarre S. The role of the central renin-angiotensin system in Parkinson’s disease. J. Renin Angiotensin Aldosterone Syst. 2010;11(1):49–56. doi:10.1177/1470320309347789
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. International Journal of Biochemistry & Cell Biology. 2003;35(6):881–900. doi:10.1016/s1357-2725(02)00271-6
   PubMed Web of Science ®Google Scholar
• Griendling KK, Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept. 2000;91(1–3):21–27. doi:10.1016/s0167-0115(00)00136-1
   PubMedGoogle Scholar
• Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ. Res. 2000;86(5):494–501. doi:10.1161/01.res.86.5.494
   PubMed Web of Science ®Google Scholar
• Allen AM, MacGregor DP, Chai SY, et al. Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann Neurol. 1992;32(3):339–344. doi:10.1002/ana.410320306
   PubMed Web of Science ®Google Scholar
• Wright JW, Kawas LH, Harding JWA. Role for the Brain RAS in Alzheimer’s and Parkinson’s Diseases. Front. Endocrinol. (Lausanne). 2013;4:158. doi:10.3389/fendo.2013.00158
   PubMedGoogle Scholar
• Strittmatter SM, Snyder SH. Angiotensin converting enzyme immunohistochemistry in rat brain and pituitary gland: correlation of isozyme type with cellular localization. Neuroscience. 1987;21(2):407–420. doi:10.1016/0306-4522(87)90131-x
   PubMed Web of Science ®Google Scholar
• Chai SY, McKenzie JS, McKinley MJ, Mendelsohn FA. Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography. Journal of Comparative Neurology. 1990;291(2):179–194. doi:10.1002/cne.902910203
   PubMed Web of Science ®Google Scholar
• Reardon KA, Mendelsohn FA, Chai SY, Horne MK. The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson’s disease. Aust. N. Z. J. Med. 2000;30(1):48–53. doi:10.1111/j.1445-5994.2000.tb01054.x
   PubMedGoogle Scholar
• Jenkins TA, Mendelsohn FA, Chai SY. Angiotensin-converting enzyme modulates dopamine turnover in the striatum. J Neurochem. 1997;68(3):1304–1311. doi:10.1046/j.1471-4159.1997.68031304.x
   PubMed Web of Science ®Google Scholar
• Chabrashvili T, Kitiyakara C, Blau J, et al. Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression. American Journal of Physiology Regulatory Integrative and Comparative Physiology. 2003;285(1):R117–124. doi:10.1152/ajpregu.00476.2002
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pallares J, Quiroz CR, Parga JA, Guerra MJ, Labandeira-Garcia JL. Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors. European Journal of Neuroscience. 2004;20(6):1489–1498. doi:10.1111/j.1460-9568.2004.03621.x
   PubMed Web of Science ®Google Scholar
• Jenkins TA, Wong JY, Howells DW, Mendelsohn FA, Chai SY. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse. J Neurochem. 1999;73(1):214–219. doi:10.1046/j.1471-4159.1999.0730214.x
   PubMed Web of Science ®Google Scholar
• Lopez-Real A, Rey P, Soto-Otero R, Mendez-Alvarez E, Labandeira-Garcia JL. Angiotensin-converting enzyme inhibition reduces oxidative stress and protects dopaminergic neurons in a 6-hydroxydopamine rat model of Parkinsonism. J Neurosci Res. 2005;81(6):865–873. doi:10.1002/jnr.20598
   PubMed Web of Science ®Google Scholar
• Munoz A, Rey P, Guerra MJ, Mendez-Alvarez E, Soto-Otero R, Labandeira-Garcia JL. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism. Neuropharmacology. 2006;51(1):112–120. doi:10.1016/j.neuropharm.2006.03.004
   PubMed Web of Science ®Google Scholar
• Babior BM. NADPH oxidase. Curr. Opin. Immunol. 2004;16(1):42–47. doi:10.1016/j.coi.2003.12.001
   PubMed Web of Science ®Google Scholar
• Rodriguez-Pallares J, Parga JA, Munoz A, Rey P, Guerra MJ, Labandeira-Garcia JL. Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem. 2007;103(1):145–156. doi:10.1111/j.1471-4159.2007.04699.x
   PubMed Web of Science ®Google Scholar
• Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, Rey P, Guerra MJ, Labandeira-Garcia JL. The inflammatory response in the MPTP model of Parkinson’s disease is mediated by brain angiotensin: relevance to progression of the disease. J Neurochem. 2009;109(2):656–669. doi:10.1111/j.1471-4159.2009.05999.x
   PubMed Web of Science ®Google Scholar
• Okamura A, Rakugi H, Ohishi M, et al. Upregulation of renin-angiotensin system during differentiation of monocytes to macrophages. J. Hypertens. 1999;17(4):537–545. doi:10.1097/00004872-199917040-00012
   PubMed Web of Science ®Google Scholar
• Labandeira-Garcia JL, Rodriguez-Pallares J, Villar-Cheda B, Rodriguez-Perez AI, Garrido-Gil P, Guerra MJ. Aging, Angiotensin system and dopaminergic degeneration in the substantia nigra. Aging Dis. 2011;2(3):257–274.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Perez AI, Valenzuela R, Joglar B, Garrido-Gil P, Guerra MJ, Labandeira-Garcia JL. Renin angiotensin system and gender differences in dopaminergic degeneration. Mol. Neurodegener. 2011;6(1):58. doi:10.1186/1750-1326-6-58
   PubMedGoogle Scholar
• Garrido-Gil P, Joglar B, Rodriguez-Perez AI, Guerra MJ, Labandeira-Garcia JL. Involvement of PPAR-gamma in the neuroprotective and anti-inflammatory effects of angiotensin type 1 receptor inhibition: effects of the receptor antagonist telmisartan and receptor deletion in a mouse MPTP model of Parkinson’s disease. J Neuroinflammation. 2012;9:38. doi:10.1186/1742-2094-9-38
   PubMed Web of Science ®Google Scholar
• Villar-Cheda B, Rodriguez-Pallares J, Valenzuela R, et al. Nigral and striatal regulation of angiotensin receptor expression by dopamine and angiotensin in rodents: implications for progression of Parkinson’s disease. European Journal of Neuroscience. 2010;32(10):1695–1706. doi:10.1111/j.1460-9568.2010.07448.x
   PubMed Web of Science ®Google Scholar
• Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581(7807):215–220. doi:10.1038/s41586-020-2180-5
   PubMed Web of Science ®Google Scholar
• Li Z, Xu X, Yang M, Feng J, Liu C, Yang C. Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic. Aging (Albany N. Y. 2020;12(23):24453–24461. doi:10.18632/aging.103993
   PubMedGoogle Scholar
• Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020;92(6):595–601. doi:10.1002/jmv.25726
   PubMed Web of Science ®Google Scholar
• Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM. Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System? A Call for Epidemiologic Investigations. Clin Infect Dis. 2020;71(15):870–874. doi:10.1093/cid/ciaa329
   PubMed Web of Science ®Google Scholar
• Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am. J. Emerg. Med. 2020;38(7):1504–1507. doi:10.1016/j.ajem.2020.04.048
   PubMed Web of Science ®Google Scholar
• Michaud V, Deodhar M, Arwood M, Al Rihani SB, Dow P, Turgeon J. ACE2 as a Therapeutic Target for COVID-19; its Role in Infectious Processes and Regulation by Modulators of the RAAS System. J Clin Med. 2020;9(7):2096. doi:10.3390/jcm9072096
   PubMed Web of Science ®Google Scholar
• Gheblawi M, Wang K, Viveiros A, et al. Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: celebrating the 20th Anniversary of the Discovery of ACE2. Circ. Res. 2020;126(10):1456–1474. doi:10.1161/CIRCRESAHA.120.317015
   PubMed Web of Science ®Google Scholar
• Morrone CD, Bishay J, McLaurin J. Potential Role of Venular Amyloid in Alzheimer’s Disease Pathogenesis. Int J Mol Sci. 2020;21(6):1985. doi:10.3390/ijms21061985
   PubMed Web of Science ®Google Scholar
• Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson’s disease. Nature. 1998;395(6701):451–452. doi:10.1038/26652
   PubMed Web of Science ®Google Scholar
• Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747–803. doi:10.1152/physrev.00036.2005
   PubMed Web of Science ®Google Scholar
• Kaur P, Muthuraman A, Kaur M. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives. ACS Chem Neurosci. 2015;6(4):508–521. doi:10.1021/cn500363g
   PubMed Web of Science ®Google Scholar
• Ohrui T, Tomita N, Sato-Nakagawa T, et al. Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression. Neurology. 2004;63(7):1324–1325. doi:10.1212/01.wnl.0000140705.23869.e9
   PubMed Web of Science ®Google Scholar
• Li NC, Lee A, Whitmer RA, et al. Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis. BMJ. 2010;340:b5465. doi:10.1136/bmj.b5465
   PubMed Web of Science ®Google Scholar
• Ongali B, Nicolakakis N, Tong XK, et al. Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer’s disease model. Neurobiol Dis. 2014;68:126–136. doi:10.1016/j.nbd.2014.04.018
   PubMed Web of Science ®Google Scholar
• Jochemsen HM, Teunissen CE, Ashby EL, et al. The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease. Alzheimers Res. Ther. 2014;6(3):27. doi:10.1186/alzrt257
   PubMed Web of Science ®Google Scholar
• Rocha NP, Toledo A, Corgosinho LTS, et al. Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-beta42 Burden in Alzheimer’s Disease. J Alzheimers Dis. 2018;64(4):1085–1090. doi:10.3233/JAD-180282
   PubMed Web of Science ®Google Scholar
• Hu J, Igarashi A, Kamata M, Nakagawa H. Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity. J Biol Chem. 2001;276(51):47863–47868. doi:10.1074/jbc.M104068200
   PubMed Web of Science ®Google Scholar
• Zou K, Liu J, Watanabe A, et al. Abeta43 is the earliest-depositing Abeta species in APP transgenic mouse brain and is converted to Abeta41 by two active domains of ACE. American Journal of Pathology. 2013;182(6):2322–2331. doi:10.1016/j.ajpath.2013.01.053
   PubMed Web of Science ®Google Scholar
• Zubenko GS, Volicer L, Direnfeld LK, Freeman M, Langlais PJ, Nixon RA. Cerebrospinal fluid levels of angiotensin-converting enzyme in Alzheimer’s disease, Parkinson’s disease and progressive supranuclear palsy. Brain Research. 1985;328(2):215–221. doi:10.1016/0006-8993(85)91032-7
   PubMed Web of Science ®Google Scholar
• Kawajiri M, Mogi M, Higaki N, et al. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis. Mult. Scler. 2009;15(2):262–265. doi:10.1177/1352458508097923
   PubMed Web of Science ®Google Scholar
• Kehoe PG, Wong S, Al Mulhim N, Palmer LE, Miners JS. Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-beta and tau pathology. Alzheimers Res. Ther. 2016;8(1):50. doi:10.1186/s13195-016-0217-7
   PubMedGoogle Scholar
• Kamel AS, Abdelkader NF, Abd El-Rahman SS, Emara M, Zaki HF, Khattab MM. Stimulation of ACE2/ANG(1–7)/Mas Axis by Diminazene Ameliorates Alzheimer’s Disease in the D-Galactose-Ovariectomized Rat Model: role of PI3K/Akt Pathway. Molecular Neurobiology. 2018;55(10):8188–8202. doi:10.1007/s12035-018-0966-3
   PubMed Web of Science ®Google Scholar
• Evans CE, Miners JS, Piva G, et al. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer’s disease. Acta Neuropathologica. 2020;139(3):485–502. doi:10.1007/s00401-019-02098-6
   PubMed Web of Science ®Google Scholar
• Zheng J, Wittouck S, Salvetti E, et al. A taxonomic note on the genus Lactobacillus: description of 23 novel genera, emended description of the genus Lactobacillus Beijerinck 1901, and union of Lactobacillaceae and Leuconostocaceae. Int J Syst Evol Microbiol. 2020;70(4):2782–2858. doi:10.1099/ijsem.0.004107
   PubMed Web of Science ®Google Scholar
• Salvetti E, Harris HMB, Felis GE, O’Toole PW, Björkroth J. Comparative genomics of the genus Lactobacillus reveals robust phylogroups that provide the basis for reclassification. Appl Environ Microbiol. 2018;84(17):e00993–00918. doi:10.1128/aem.00993-18
   PubMed Web of Science ®Google Scholar
• Zheng J, Ruan L, Sun M, Gänzle M, Björkroth J. A genomic view of lactobacilli and pediococci demonstrates that phylogeny matches ecology and physiology. Appl Environ Microbiol. 2015;81(20):7233–7243. doi:10.1128/aem.02116-15
   PubMed Web of Science ®Google Scholar
• Sun Z, Harris HMB, McCann A, et al. Expanding the biotechnology potential of lactobacilli through comparative genomics of 213 strains and associated genera. Nature Communications. 2015;6(1):8322. doi:10.1038/ncomms9322
   PubMedGoogle Scholar
• Duar RM, Lin XB, Zheng J, et al. Lifestyles in transition: evolution and natural history of the genus Lactobacillus. FEMS Microbiology Reviews. 2017;41(1):27–48. doi:10.1093/femsre/fux030
   PubMedGoogle Scholar
• Martino ME, Bayjanov JR, Caffrey BE, et al. Nomadic lifestyle of Lactobacillus plantarum revealed by comparative genomics of 54 strains isolated from different habitats. Environmental Microbiology. 2016;18(12):4974–4989. doi:10.1111/1462-2920.13455
   PubMed Web of Science ®Google Scholar
• Rossi M, Martinez-Martinez D, Amaretti A, Ulrici A, Raimondi S, Moya A. Mining metagenomic whole genome sequences revealed subdominant but constant Lactobacillus population in the human gut microbiota. Environmental Microbiology Reports. 2016;8(3):399–406. doi:10.1111/1758-2229.12405
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lv J, Pan L, Zhang Y. Roles and applications of probiotic Lactobacillus strains. Appl Microbiol Biotechnol. 2018;102(19):8135–8143. doi:10.1007/s00253-018-9217-9
   PubMed Web of Science ®Google Scholar
• Achuthan AA, Duary RK, Madathil A, et al. Antioxidative potential of lactobacilli isolated from the gut of Indian people. Mol Biol Rep. 2012;39(8):7887–7897. doi:10.1007/s11033-012-1633-9
   PubMed Web of Science ®Google Scholar
• Mishra V, Shah C, Mokashe N, Chavan R, Yadav H, Prajapati J. Probiotics as potential antioxidants: a systematic review. J. Agric. Food Chem. 2015;63(14):3615–3626. doi:10.1021/jf506326t
   PubMed Web of Science ®Google Scholar
• Kleniewska P, Hoffmann A, Pniewska E, Pawliczak R. The influence of probiotic Lactobacillus casei in combination with prebiotic inulin on the antioxidant capacity of human plasma. Oxid. Med. Cell. Longev. 2016;2016:1–10. doi:10.1155/2016/1340903
   Web of Science ®Google Scholar
• Westfall S, Lomis N, Prakash S. Ferulic acid produced by Lactobacillus fermentum influences developmental growth through a dTOR-mediated mechanism. Mol Biotechnol. 2018;61(1):1–11. doi:10.1007/s12033-018-0119-y
   Web of Science ®Google Scholar
• Fung TC. The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis. 2020;136:104714. doi:10.1016/j.nbd.2019.104714
   PubMed Web of Science ®Google Scholar
• Danilenko VN, Marsova MV, Poluektova EU. The use of cells of the strain Lactobacillus fermentum U-21 and biologically active substances obtained from them. Patent No. RU2019141103A by 11.06.2021. 2021. 1–26.
   Google Scholar
• Bhandari P, Rishi P, Prabha V. Positive effect of probiotic Lactobacillus plantarum in reversing LPS-induced infertility in a mouse model. J Med Microbiol. 2016;65(5):345–350. doi:10.1099/jmm.0.000230
   PubMedGoogle Scholar
• Grompone G, Martorell P, Llopis S, et al. Anti-inflammatory Lactobacillus rhamnosus CNCM I-3690 strain protects against oxidative stress and increases lifespan in Caenorhabditis elegans. PLoS One. 2012;7(12):e52493. doi:10.1371/journal.pone.0052493
   PubMed Web of Science ®Google Scholar
• Lee J, Yang W, Hostetler A, et al. Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. BMC Microbiol. 2016;16:69. doi:10.1186/s12866-016-0686-7
   PubMed Web of Science ®Google Scholar
• Choi SS, Kim Y, Han KS, You S, Oh S, Kim SH. Effects of Lactobacillus strains on cancer cell proliferation and oxidative stress in vitro. Lett Appl Microbiol. 2006;42(5):452–458. doi:10.1111/j.1472-765X.2006.01913.x
   PubMed Web of Science ®Google Scholar
• Noureen S, Riaz A, Arshad M, Arshad N. In vitro selection and in vivo confirmation of the antioxidant ability of Lactobacillus brevis MG000874. J Appl Microbiol. 2019;126(4):1221–1232. doi:10.1111/jam.14189
   PubMed Web of Science ®Google Scholar
• Marsova M, Poluektova E, Odorskaya M, et al. Protective effects of Lactobacillus fermentum U-21 against paraquat-induced oxidative stress in Caenorhabditis elegans and mouse models. World J Microbiol Biotechnol. 2020a;36(7):104. doi:10.1007/s11274-020-02879-2
   PubMed Web of Science ®Google Scholar
• Marsova M, Odorskaya M, Novichkova M, et al. The Lactobacillus brevis 47 f Strain Protects the Murine Intestine from Enteropathy Induced by 5-Fluorouracil. Microorganisms. 2020b;8(6):876. doi:10.3390/microorganisms8060876
   PubMed Web of Science ®Google Scholar
• Miraghajani M, Zaghian N, Mirlohi M, Feizi A, Ghiasvand R. The Impact of Probiotic Soy Milk Consumption on Oxidative Stress Among Type 2 Diabetic Kidney Disease Patients: a Randomized Controlled Clinical Trial. J. Ren. Nutr. 2017;27(5):317–324. doi:10.1053/j.jrn.2017.04.004
   PubMed Web of Science ®Google Scholar
• Soleimani A, Zarrati Mojarrad M, Bahmani F, et al. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int. 2017;91(2):435–442. doi:10.1016/j.kint.2016.09.040
   PubMed Web of Science ®Google Scholar
• Amaretti A, Nunzio M, Pompei A, Raimondi S, Rossi M, Bordoni A. Antioxidant properties of potentially probiotic bacteria: in vitro and in vivo activities. Appl Microbiol Biotechnol. 2012;97(2):809–817. doi:10.1007/s00253-012-4241-7
   PubMed Web of Science ®Google Scholar
• Ho L, Ono K, Tsuji M, Mazzola P, Singh R, Pasinetti GM. Protective roles of intestinal microbiota derived short chain fatty acids in Alzheimer’s disease-type beta-amyloid neuropathological mechanisms. Expert Rev. Neurother. 2017;18(1):83–90. doi:10.1080/14737175.2018.1400909
   PubMed Web of Science ®Google Scholar
• Nowak A, Paliwoda A, Błasiak J. Anti-proliferative, pro-apoptotic and anti-oxidative activity of Lactobacillus and Bifidobacterium strains: a review of mechanisms and therapeutic perspectives. Crit. Rev. Food Sci. Nutr. 2018;59(21):3456–3467. doi:10.1080/10408398.2018.1494539
   PubMed Web of Science ®Google Scholar
• Attia HN, Maklad YA. Neuroprotective effects of coenzyme Q10 on paraquat-induced Parkinson’s disease in experimental animals. Behav. Pharmacol. 2018;29(1):79–86. doi:10.1097/fbp.0000000000000342
   PubMed Web of Science ®Google Scholar
• Flanagan E, Müller M, Hornberger M, Vauzour D. Impact of flavonoids on cellular and molecular mechanisms underlying age-related cognitive decline and neurodegeneration. Curr Nutr Rep. 2018;7(2):49–57. doi:10.1007/s13668-018-0226-1
   PubMedGoogle Scholar
• Haddadi R, Nayebi AM, Eyvari Brooshghalan S. Silymarin prevents apoptosis through inhibiting the Bax/caspase-3 expression and suppresses toll like receptor-4 pathway in the SNc of 6-OHDA intoxicated rats. Biomed. Pharmacother. 2018;104:127–136. doi:10.1016/j.biopha.2018.05.020
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang L, Li L, Hölscher C. Neuroprotective effects of the novel GLP-1 long acting analogue semaglutide in the MPTP Parkinson’s disease mouse model. Neuropeptides. 2018;71:70–80. doi:10.1016/j.npep.2018.07.003
   PubMed Web of Science ®Google Scholar
• Ganji-Arjenaki M, Rafieian-Kopaei M. Probiotics are a good choice in remission of inflammatory bowel diseases: a meta analysis and systematic review. J Cell Physiol. 2018;233(3):2091–2103. doi:10.1002/jcp.25911
   PubMed Web of Science ®Google Scholar
• Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–1270. doi:10.1016/j.cell.2012.01.035
   PubMed Web of Science ®Google Scholar
• Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature Reviews Neuroscience. 2012;13(10):701–712. doi:10.1038/nrn3346
   PubMed Web of Science ®Google Scholar
• Maslowski KM, Mackay CR. Diet, gut microbiota and immune responses. Nat. Immunol. 2010;12(1):5–9. doi:10.1038/ni0111-5
   Web of Science ®Google Scholar
• Perez-Pardo P, Kliest T, Dodiya HB, et al. The gut-brain axis in Parkinson’s disease: possibilities for food-based therapies. Eur J Pharmacol. 2017;817:86–95. doi:10.1016/j.ejphar.2017.05.042
   PubMed Web of Science ®Google Scholar
• Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc. 2015;12(2):150–156. doi:10.1513/AnnalsATS.201503-133AW
   Google Scholar
• Dang AT, Marsland BJ. Microbes, metabolites, and the gut–lung axis. Mucosal Immunol. 2019;12(4):843–850. doi:10.1038/s41385-019-0160-6
   PubMed Web of Science ®Google Scholar
• Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson’s disease. J. Parkinsons Dis. 2013;3(4):461–491. doi:10.3233/jpd-130230
   PubMedGoogle Scholar
• Rao M, Gershon MD. The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastro Hepat. 2016;13(9):517–528. doi:10.1038/nrgastro.2016.107
   PubMed Web of Science ®Google Scholar
• Wang N, Song G, Yang Y, Yuan W, Qi M. Inactivated Lactobacillus promotes protection against myocardial ischemia–reperfusion injury through NF-κB pathway. Biosci Rep. 2017;37(6):BSR20171025. doi:10.1042/bsr20171025
   PubMedGoogle Scholar
• Sun M-F, Zhu Y-L, Zhou Z-L, et al. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson’s disease mice: gut microbiota, glial reaction and TLR4/TNF-α signaling pathway. Brain, Behav., Immun. 2018;70:48–60. doi:10.1016/j.bbi.2018.02.005
   PubMed Web of Science ®Google Scholar
• Wanchao S, Chen M, Zhiguo S, Futang X, Mengmeng S. Protective effect and mechanism of Lactobacillus on cerebral ischemia reperfusion injury in rats. Braz J Med Biol Res. 2018;51(7):e7172. doi:10.1590/1414-431x20187172
   PubMed Web of Science ®Google Scholar
• Fukai T, Ushio-Fukai M. Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Sign. 2011;15(6):1583–1606. doi:10.1089/ars.2011.3999
   PubMed Web of Science ®Google Scholar
• Miriyala S, Spasojevic I, Tovmasyan A, et al. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta. 2012;1822(5):794–814. doi:10.1016/j.bbadis.2011.12.002
   PubMed Web of Science ®Google Scholar
• Calder PC, Albers R, Antoine JM, et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr. 2009;101(S1):1–45. doi:10.1017/s0007114509377867
   Google Scholar
• Ramalho R, Rao M, Zhang C, et al. Immunometabolism: new insights and lessons from antigen-directed cellular immune responses. Semin Immunopathol. 2020;42(3):279–313. doi:10.1007/s00281-020-00798-w
   PubMed Web of Science ®Google Scholar
• Xue J, Ajuwon KM, Fang R. Mechanistic insight into the gut microbiome and its interaction with host immunity and inflammation. Anim Nutr. 2020;6(4):421–428. doi:10.1016/j.aninu.2020.05.007
   PubMedGoogle Scholar
• Schubert M-L, Rohrbach R, Schmitt M, Stein-Thoeringer CK. The potential role of the intestinal micromilieu and individual microbes in the immunobiology of chimeric antigen receptor T-cell therapy. Front Immunol. 2021;12:1836. doi:10.3389/fimmu.2021.670286
   Web of Science ®Google Scholar
• Xing C, Wang M, Ajibade AA, et al. Microbiota regulate innate immune signaling and protective immunity against cancer. Cell Host Microbe. 2021;29(6):959–974. doi:10.1016/j.chom.2021.03.016
   PubMed Web of Science ®Google Scholar
• Averina OV, Danilenko VN. Human intestinal microbiota: role in development and functioning of the nervous system. Microbiology. 2017;86(1):1–18. doi:10.1134/S0026261717010040
   Web of Science ®Google Scholar
• Bhattarai Y. Microbiota-gut-brain axis: interaction of gut microbes and their metabolites with host epithelial barriers. Neurogastroenterol Motil. 2018;30(6):e13366. doi:10.1111/nmo.13366
   PubMed Web of Science ®Google Scholar
• Kerksick C, Willoughby D. The antioxidant role of glutathione and N-acetyl-cysteine supplements and exercise-induced oxidative stress. J Int Soc Sports Nutr. 2005;2(2):38. doi:10.1186/1550-2783-2-2-38
   PubMedGoogle Scholar
• Jung K-A, Kwak M-K. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15(10):7266–7291. doi:10.3390/molecules15107266
   PubMed Web of Science ®Google Scholar
• Kullisaar T, Songisepp E, Aunapuu M, et al. Complete glutathione system in probiotic Lactobacillus fermentum ME-3. Appl Biochem Microbiol. 2010;46(5):527–531. doi:10.1134/S0003683810050030
   Web of Science ®Google Scholar
• Falony G, Joossens M, Vieira-Silva S, et al. Population-level analysis of gut microbiome variation. Science. 2016;352(6285):560–564. doi:10.1126/science.aad3503
   PubMed Web of Science ®Google Scholar
• Tang W, Xing Z, Li C, Wang J, Wang Y. Molecular mechanisms and in vitro antioxidant effects of Lactobacillus plantarum MA2. Food Chem. 2017;221:1642–1649. doi:10.1016/j.foodchem.2016.10.124
   PubMed Web of Science ®Google Scholar
• Main PAE, Angley MT, O’Doherty CE, Thomas P, Fenech M. The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysis. Nutr. Metab. (Lond. 2012;9(1):35. doi:10.1186/1743-7075-9-35
   PubMedGoogle Scholar
• Pophaly SD, Singh R, Pophaly SD, Kaushik JK, Tomar SK. Current status and emerging role of glutathione in food grade lactic acid bacteria. Microb Cell Fact. 2012;11(1):114. doi:10.1186/1475-2859-11-114
   PubMedGoogle Scholar
• Lin J, Zou Y, Cao K, Ma C, Chen Z. The impact of heterologous catalase expression and superoxide dismutase overexpression on enhancing the oxidative resistance in Lactobacillus casei. J Ind Microbiol Biotechnol. 2016;43(5):703–711. doi:10.1007/s10295-016-1752-8
   PubMed Web of Science ®Google Scholar
• García-Giménez JL, Ibañez-Cabellos JS, Seco-Cervera M, Pallardó F. S1-1 - glutathione and cellular redox control in epigenetic regulation. Free Radic. Biol. Med. 2014;75:3. doi:10.1016/j.freeradbiomed.2014.10.828
   Web of Science ®Google Scholar
• Laiño J, Villena J, Kanmani P, Kitazawa H. Immunoregulatory effects triggered by lactic acid bacteria exopolysaccharides: new insights into molecular interactions with host cells. Microorganisms. 2016;4(3):27. doi:10.3390/microorganisms4030027
   PubMed Web of Science ®Google Scholar
• Lyu C, Hu S, Huang J, et al. Contribution of the activated catalase to oxidative stress resistance and γ-aminobutyric acid production in Lactobacillus brevis. Int. J. Food Microbiol. 2016;238:302–310. doi:10.1016/j.ijfoodmicro.2016.09.023
   PubMed Web of Science ®Google Scholar
• Mahdhi A, Leban N, Chakroun I, et al. Extracellular polysaccharide derived from potential probiotic strain with antioxidant and antibacterial activities as a prebiotic agent to control pathogenic bacterial biofilm formation. Microb. Pathog. 2017;109:214–220. doi:10.1016/j.micpath.2017.05.046
   PubMed Web of Science ®Google Scholar
• Danilenko VN, Marsova MV, Poluektova EU, Odorskaya MV, Yunes RA. Lactobacillus fermentum U-21 strain, which produces complex of biologically active substances which neutralize superoxide anion induced by chemical agents. Patent No. 2705250 by 05.02.2018. 2018. 1–16.
   Google Scholar
• Danilenko VN, Marsova MV, Poluektova EU. The use of cells of the Lactobacillus fermentum U-21 strain and biologically active substances obtained from them. Patent No. 2019141103/20 (080350) by 11.12.2019. 2019. 1–24.
   Google Scholar
• Danilenko VN, Stavrovskaya AV, Voronkov D, et al. The use of a pharmabiotic based on the Lactobacillus fermentum U-21 strain to modulate the neurodegenerative process in an experimental model of Parkinson’s disease. Annals of Clinical and Experimental Neurology. 2020;14:62–69. doi:10.25692/ACEN.2020.1.7
   Google Scholar
• Scheperjans F, Aho V, Pereira PAB, et al. Gut microbiota are related to Parkinson’s disease and clinical phenotype. Mov Disord. 2014;30(3):350–358. doi:10.1002/mds.26069
   PubMed Web of Science ®Google Scholar
• Petrov VA, Saltykova IV, Zhukova IA, et al. Analysis of gut microbiota in patients with Parkinson’s disease. Bull Exp Biol Med. 2017;162(6):734–737. doi:10.1007/s10517-017-3700-7
   PubMed Web of Science ®Google Scholar
• Bedarf JR, Hildebrand F, Coelho LP, et al. Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson’s disease patients. Genome Med. 2017;9(1):39. doi:10.1186/s13073-017-0428-y
   PubMedGoogle Scholar
• Antunes AEC, Vinderola G, Xavier-Santos D, Sivieri K. Potential contribution of beneficial microbes to face the COVID-19 pandemic. Food Res. Int. 2020;136:109577. doi:10.1016/j.foodres.2020.109577
   PubMed Web of Science ®Google Scholar
• Xiang Z, Koo H, Chen Q, Zhou X, Liu Y, Simon-Soro A. Potential implications of SARS-CoV-2 oral infection in the host microbiota. J. Oral Microbiol. 2020;13(1):1853451. doi:10.1080/20002297.2020.1853451
   PubMed Web of Science ®Google Scholar
• Follmer C. Viral infection-induced gut dysbiosis, neuroinflammation, and alpha-synuclein aggregation: updates and perspectives on COVID-19 and neurodegenerative disorders. ACS Chem Neurosci. 2020;11(24):4012–4016. doi:10.1021/acschemneuro.0c00671
   PubMed Web of Science ®Google Scholar
• Boulangé CL, Neves AL, Chilloux J, Nicholson JK, Dumas M-E. Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Med. 2016;8(1):42. doi:10.1186/s13073-016-0303-2
   PubMedGoogle Scholar
• Wang Z, Zhao Y. Gut microbiota derived metabolites in cardiovascular health and disease. Protein Cell. 2018;9(5):416–431. doi:10.1007/s13238-018-0549-0
   PubMed Web of Science ®Google Scholar
• De Luca F, Shoenfeld Y. The microbiome in autoimmune diseases. Clin Exp Immunol. 2019;195(1):74–85. doi:10.1111/cei.13158
   PubMed Web of Science ®Google Scholar
• Xu H, Liu M, Cao J, et al. The dynamic interplay between the gut microbiota and autoimmune diseases. Journal of Immunology Research. 2019;2019:1–14. doi:10.1155/2019/7546047
   Web of Science ®Google Scholar
• Goulet O. Potential role of the intestinal microbiota in programming health and disease: figure 1. Nutr Rev. 2015;73(\(suppl 1)):32–40. doi:10.1093/nutrit/nuv039
   PubMedGoogle Scholar
• Needell JC, Zipris D. The role of the intestinal microbiome in type 1 diabetes pathogenesis. Curr. Diab. Rep. 2016;16(10):89. doi:10.1007/s11892-016-0781-z
   PubMed Web of Science ®Google Scholar
• Biscetti F, Nardella E, Cecchini AL, Landolfi R, Flex A. The role of the microbiota in the diabetic peripheral artery disease. Mediators Inflamm. 2019;2019:1–16. doi:10.1155/2019/4128682
   Web of Science ®Google Scholar
• Huang YJ, Marsland BJ, Bunyavanich S, et al. The microbiome in allergic disease: current understanding and future opportunities. J. Allergy Clin. Immunol. 2017;139(4):1099–1110. doi:10.1016/j.jaci.2017.02.007
   PubMed Web of Science ®Google Scholar
• Haikal C, Chen QQ, Li JY. Microbiome changes: an indicator of Parkinson’s disease? Transl Neurodegener. 2019;8:38. doi:10.1186/s40035-019-0175-7
   PubMed Web of Science ®Google Scholar
• Averina OV, Zorkina YA, Yunes RA, et al. Bacterial metabolites of human gut microbiota correlating with depression. Int J Mol Sci. 2020b;21(23):9234. doi:10.3390/Ijms21239234
   PubMed Web of Science ®Google Scholar
• Du Y, Gao X-R, Peng L, Ge J-F. Crosstalk between the microbiota-gut-brain axis and depression. Heliyon. 2020;6(6):e04097. doi:10.1016/j.heliyon.2020.e04097
   PubMed Web of Science ®Google Scholar
• Ding HT, Taur Y, Walkup JT. Gut microbiota and autism: key concepts and findings. J. Autism Dev. Disord. 2016;47(2):480–489. doi:10.1007/s10803-016-2960-9
   Web of Science ®Google Scholar
• Chen -W-W, Zhang XIA, Huang W-J. Role of neuroinflammation in neurodegenerative diseases (Review). Mol Med Report. 2016;13(4):3391–3396. doi:10.3892/mmr.2016.4948
   PubMed Web of Science ®Google Scholar
• Siniscalco D, Schultz S, Brigida A, Antonucci N. Inflammation and neuro-immune dysregulations in autism spectrum disorders. Pharmaceuticals. 2018;11(2):56. doi:10.3390/ph11020056
   Web of Science ®Google Scholar
• Prata J, Machado AS, von Doellinger O, et al. The contribution of inflammation to autism spectrum disorders: recent clinical evidence. Methods Mol Biol. 2019;2011:493–510. doi:10.1007/978-1-4939-9554-7_29
   PubMedGoogle Scholar
• Keshavarzian A, Green SJ, Engen PA, et al. Colonic bacterial composition in Parkinson’s disease. Mov Disord. 2015;30(10):1351–1360. doi:10.1002/mds.26307
   PubMed Web of Science ®Google Scholar
• Pereira PAB, Aho VTE, Paulin L, Pekkonen E, Auvinen P, Scheperjans F. Oral and nasal microbiota in Parkinson’s disease. Parkinsonism Relat Disord. 2017;38:61–67. doi:10.1016/j.parkreldis.2017.02.026
   PubMed Web of Science ®Google Scholar
• Heintz-Buschart A, Pandey U, Wicke T, et al. The nasal and gut microbiome in Parkinson’s disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 2018;33(1):88–98. doi:10.1002/mds.27105
   PubMed Web of Science ®Google Scholar
• Minato T, Maeda T, Fujisawa Y, et al. Progression of Parkinson’s disease is associated with gut dysbiosis: two-year follow-up study. PLoS One. 2017;12(11):e0187307. doi:10.1371/journal.pone.0187307
   PubMed Web of Science ®Google Scholar
• Hasegawa S, Goto S, Tsuji H, et al. Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson’s disease. Mov Disord. 2016;31:S40–S40. doi:10.1371/journal.pone.0142164
   Web of Science ®Google Scholar
• Hopfner F, Kunstner A, Muller SH, et al. Gut microbiota in Parkinson disease in a northern German cohort. Brain Res. 2017;1667:41–45. doi:10.1016/j.brainres.2017.04.019
   PubMed Web of Science ®Google Scholar
• Scheperjans F, Aho V, Pereira PAB, et al. Gut Microbiota Are Related to Parkinson’s Disease and Clinical Phenotype. Mov Disord. 2015;30(3):350–358. doi:10.1002/mds.26069
   PubMed Web of Science ®Google Scholar
• Lin CH, Chen CC, Chiang HL, et al. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease. J Neuroinflammation. 2019;16(1):129. doi:10.1186/s12974-019-1528-y
   PubMedGoogle Scholar
• Aho VTE, Pereira PAB, Voutilainen S, et al. Gut microbiota in Parkinson’s disease: temporal stability and relations to disease progression. EBioMedicine. 2019;44:691–707. doi:10.1016/j.ebiom.2019.05.064
   PubMed Web of Science ®Google Scholar
• Hill-Burns EM, Debelius JW, Morton JT, et al. Parkinson’s Disease and Parkinson’s Disease Medications Have Distinct Signatures of the Gut Microbiome. Mov Disord. 2017;32(5):739–749. doi:10.1002/mds.26942
   PubMed Web of Science ®Google Scholar
• Mihaila D, Donegan J, Barns S, et al. The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function. PLoS One. 2019;14(6):e0218252. doi:10.1371/journal.pone.0218252
   PubMed Web of Science ®Google Scholar
• Lin AQ, Zheng WX, He Y, et al. Gut microbiota in patients with Parkinson’s disease in southern China. Parkinsonism Relat Disord. 2018;53:82–88. doi:10.1016/j.parkreldis.2018.05.007
   PubMed Web of Science ®Google Scholar
• Li W, Wu XL, Hu X, et al. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Science China-Life Sciences. 2017;60(11):1223–1233. doi:10.1007/s11427-016-9001-4
   PubMed Web of Science ®Google Scholar
• Perez-Pardo P, Dodiya HB, Engen PA, et al. Gut bacterial composition in a mouse model of Parkinson’s disease. Benef Microbes. 2018;9(5):799–814. doi:10.3920/BM2017.0202
   PubMed Web of Science ®Google Scholar
• Pietrucci D, Cerroni R, Unida V, et al. Dysbiosis of gut microbiota in a selected population of Parkinson’s patients. Parkinsonism Relat Disord. 2019;65:124–130. doi:10.1016/j.parkreldis.2019.06.003
   PubMed Web of Science ®Google Scholar
• Qian Y, Yang X, Xu S, et al. Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease. Brain. Behav. Immun. 2018;70:194–202. doi:10.1016/j.bbi.2018.02.016
   PubMed Web of Science ®Google Scholar
• Li F, Wang P, Chen Z, Sui X, Xie X, Zhang J. Alteration of the fecal microbiota in North-Eastern Han Chinese population with sporadic Parkinson’s disease. Neuroscience Letters. 2019;707:134297. doi:10.1016/j.neulet.2019.134297
   PubMed Web of Science ®Google Scholar
• Ansaldo E, Slayden LC, Ching KL, et al. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 2019;364(6446):1179. doi:10.1126/science.aaw7479
   PubMed Web of Science ®Google Scholar
• Zuo T, Zhang F, Lui GCY, et al. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization. Gastroenterology. 2020;159(3):944–955 e948. doi:10.1053/j.gastro.2020.05.048
   PubMed Web of Science ®Google Scholar
• Zuo T, Liu Q, Zhang F, et al. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19. Gut. 2021;70(2):276–284. doi:10.1136/gutjnl-2020-322294
   PubMed Web of Science ®Google Scholar
• Gu S, Chen Y, Wu Z, et al. Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 Influenza. Clin Infect Dis. 2020;71(10):2669–2678. doi:10.1093/cid/ciaa709
   PubMed Web of Science ®Google Scholar
• Tao W, Zhang G, Wang X, et al. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Med Microecol. 2020;5:100023. doi:10.1016/j.medmic.2020.100023
   PubMedGoogle Scholar
• Yamamoto S, Saito M, Tamura A, Prawisuda D, Mizutani T, Yotsuyanagi H. The human microbiome and COVID-19: a systematic review. PLoS One. 2021;16(6):e0253293. doi:10.1371/journal.pone.0253293
   PubMedGoogle Scholar
• Brown SP, Cornforth DM, Mideo N. Evolution of virulence in opportunistic pathogens: generalism, plasticity, and control. Trends Microbiol. 2012;20(7):336–342. doi:10.1016/j.tim.2012.04.005
   PubMed Web of Science ®Google Scholar
• Xu K, Cai H, Shen Y, et al. Management of COVID-19: the Zhejiang experience. Journal of Zhejiang University. Medical Sciences. 2020;49(2):147–157. doi:10.3785/j.issn.1008-9292.2020.02.02
   Google Scholar
• Shen Z, Xiao Y, Kang L, et al. Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020;71(15):713–720. doi:10.1093/cid/ciaa203
   PubMed Web of Science ®Google Scholar
• De Maio F, Posteraro B, Ponziani FR, Cattani P, Gasbarrini A, Sanguinetti M. Nasopharyngeal Microbiota Profiling of SARS-CoV-2 Infected Patients. Biological Procedures Online. 2020;22:18. doi:10.1186/s12575-020-00131-7
   PubMed Web of Science ®Google Scholar
• Elsayed S, Zhang K. Human infection caused by Clostridium hathewayi. Emerg Infect Dis. 2004;10(11):1950–1952. doi:10.3201/eid1011.040006
   PubMed Web of Science ®Google Scholar
• Tamilselvi R, Dakshinamoorthy M, Venkatesh A, Arumugam K. A Literature Review on Dental Caries Vaccine-A Prevention Strategy. Indian Journal of Public Health Research and Development. 2019;10:3041.
   Google Scholar
• Tang L, Gu S, Gong Y, et al. Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity. Engineering (Beijing, China). 2020;6(10):1178–1184. doi:10.1016/j.eng.2020.05.013
   PubMedGoogle Scholar
• Montefusco L, Ben Nasr M, D’Addio F, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774–785. doi:10.1038/s42255-021-00407-6
   PubMedGoogle Scholar
• Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259–264. doi:10.1038/s41586-021-03553-9
   PubMed Web of Science ®Google Scholar
• Weng J, Li Y, Li J, et al. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021;6(5):344–346. doi:10.1016/S2468-1253(21)00076-5
   PubMed Web of Science ®Google Scholar
• Chen Y, Gu S, Chen Y, et al. Six-month follow-up of gut microbiota richness in patients with COVID-19. Gut. 2021;1:gutjnl-2021-324090. doi:10.1136/gutjnl-2021-324090
   Google Scholar
• Sokol H, Contreras V, Maisonnasse P, et al. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota. Gut Microbes. 2021;13(1):1–19. doi:10.1080/19490976.2021.1893113
   PubMed Web of Science ®Google Scholar
• Yeoh YK, Zuo T, Lui GC, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70(4):698–706. doi:10.1136/gutjnl-2020-323020
   PubMed Web of Science ®Google Scholar
• Poluektova E, Yunes R, Danilenko V. The putative antidepressant mechanisms of probiotic bacteria: relevant genes and proteins. Nutrients. 2021;13(5):1591. doi:10.3390/nu13051591
   PubMed Web of Science ®Google Scholar
• Nezametdinova VZ, Yunes RA, Dukhinova MS, Alekseeva MG, Danilenko VN. The role of the PFNA operon in the recognition of host’s immune signals: prospects for the use of the FN3 protein in the treatment of COVID-19. Int J Mol Sci. 2021;22:9219. doi:10.3390/ijms22179219
   PubMed Web of Science ®Google Scholar
• Belkina TV, Averina OV, Savenkova EV, Danilenko VN. Human intestinal microbiome and the immune system: the role of probiotics in shaping an immune system unsusceptible to COVID-19 infection. Biology Bulletin Reviews. 2021;11(4):523–539. doi:10.1134/S2079086421040034
   Google Scholar
• Suvarna V, Baviskar N. The clinical overview on natural immunopolysaccharides as an adjuvant therapy of cancer. Int J Pharm Sci Res. 2021;12(7):3521–3536. doi:10.13040/ijpsr.0975-8232
   Google Scholar
• Gentile F, Doneddu PE, Riva N, Nobile-Orazio E, Quattrini A. Diet, microbiota and brain health: unraveling the network intersecting metabolism and neurodegeneration. Int J Mol Sci. 2020;21(20):7471. doi:10.3390/ijms21207471
   PubMed Web of Science ®Google Scholar
• Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nature Reviews Microbiology. 2020;19(1):55–71. doi:10.1038/s41579-020-0433-9
   PubMed Web of Science ®Google Scholar
• Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature. 2011;473(7346):174–180. doi:10.1038/nature09944
   PubMed Web of Science ®Google Scholar
• Lynch SV, Phimister EG, Pedersen O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 2016;375(24):2369–2379. doi:10.1056/NEJMra1600266
   PubMed Web of Science ®Google Scholar
• Almeida A, Mitchell AL, Boland M, et al. A new genomic blueprint of the human gut microbiota. Nature. 2019;568(7753):499–504. doi:10.1038/s41586-019-0965-1
   PubMed Web of Science ®Google Scholar
• Hasan N, Yang H. Factors affecting the composition of the gut microbiota, and its modulation. PeerJ. 2019;7:e7502. doi:10.7717/peerj.7502
   PubMed Web of Science ®Google Scholar
• Tyakht AV, Kostryukova ES, Popenko AS, et al. Human gut microbiota community structures in urban and rural populations in Russia. Nature Communications. 2013;4(1):2469. doi:10.1038/ncomms3469
   PubMedGoogle Scholar
• Wilson AS, Koller KR, Ramaboli MC, et al. Diet and the human gut microbiome: an international review. Dig Dis Sci. 2020;65(3):723–740. doi:10.1007/s10620-020-06112-w
   PubMed Web of Science ®Google Scholar
• Aziz Q, Doré J, Emmanuel A, Guarner F, Quigley EMM. Gut microbiota and gastrointestinal health: current concepts and future directions. Neurogastroenterol Motil. 2013;25(1):4–15. doi:10.1111/nmo.12046
   PubMed Web of Science ®Google Scholar
• Jandhyala SM. Role of the normal gut microbiota. World J Gastroenterol. 2015;21(29):8787. doi:10.3748/wjg.v21.i29.8787
   PubMed Web of Science ®Google Scholar
• Krishnan S, Alden N, Lee K. Pathways and functions of gut microbiota metabolism impacting host physiology. Curr Opin Biotechnol. 2015;36:137–145. doi:10.1016/j.copbio.2015.08.015
   PubMed Web of Science ®Google Scholar
• Marchesi JR, Adams DH, Fava F, et al. The gut microbiota and host health: a new clinical frontier. Gut. 2016;65(2):330–339. doi:10.1136/gutjnl-2015-309990
   PubMed Web of Science ®Google Scholar
• Plaza-Diaz J, Ruiz-Ojeda FJ, Gil-Campos M, Gil A. Mechanisms of action of probiotics. Adv. Nutr. 2019;10(suppl_1):49–66. doi:10.1093/advances/nmy063
   PubMed Web of Science ®Google Scholar
• Blaak EE, Canfora EE, Theis S, et al. Short chain fatty acids in human gut and metabolic health. Benef Microbes. 2020;11(5):411–455. doi:10.3920/bm2020.0057
   PubMed Web of Science ®Google Scholar
• Evans JM, Morris LS, Marchesi JR. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol. 2013;218(3):37–47. doi:10.1530/joe-13-0131
   Web of Science ®Google Scholar
• Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014;28(8):1221–1238. doi:10.1210/me.2014-1108
   PubMed Web of Science ®Google Scholar
• Sharma L, Riva A. Intestinal barrier function in health and disease - any role of SARS-CoV-2? Microorganisms. 2020;8(11):1744. doi:10.3390/microorganisms8111744
   PubMed Web of Science ®Google Scholar
• Yang Y, Huang W, Fan Y, Chen G-Q. Gastrointestinal microenvironment and the gut-lung axis in the immune responses of severe COVID-19. Front Mol Biosci. 2021;8:647508. doi:10.3389/fmolb.2021.647508
   PubMed Web of Science ®Google Scholar
• Lopes RCSO, Balbino KP, Jorge MP, Ribeiro AQ, Martino HSD, Alfenas RCG. Modulation of intestinal microbiota, control of nitrogen products and inflammation by pre/probiotics in chronic kidney disease: a systematic review. Nutr. Hosp. 2018;35(3):722–730. doi:10.20960/nh.1642
   PubMed Web of Science ®Google Scholar
• Plata C, Cruz C, Cervantes LG, Ramírez V. The gut microbiota and its relationship with chronic kidney disease. Int. Urol. Nephrol. 2019;51(12):2209–2226. doi:10.1007/s11255-019-02291-2
   PubMed Web of Science ®Google Scholar
• Tao S, Tao S, Cheng Y, Liu J, Ma L, Fu P. Effects of probiotic supplements on the progression of chronic kidney disease: a meta‐analysis. Nephrology. 2019;24(11):1122–1130. doi:10.1111/nep.13549
   PubMed Web of Science ®Google Scholar
• Fontana L, Plaza-Diaz J, Robles-Bolivar P, et al. Bifidobacterium breve CNCM I-4035, Lactobacillus paracasei CNCM I-4034 and Lactobacillus rhamnosus CNCM I-4036 modulate macrophage gene expression and ameliorate damage markers in the liver of Zucker-Lepr(fa/ fa) rats. Nutrients. 2021;13(1):202. doi:10.3390/Nu13010202
   PubMed Web of Science ®Google Scholar
• Tunapong W, Apaijai N, Yasom S, et al. Chronic treatment with prebiotics, probiotics and synbiotics attenuated cardiac dysfunction by improving cardiac mitochondrial dysfunction in male obese insulin-resistant rats. Eur J Nutr. 2017;57(6):2091–2104. doi:10.1007/s00394-017-1482-3
   PubMed Web of Science ®Google Scholar
• Bermudez-Humaran LG, Salinas E, Ortiz GG, Ramirez-Jirano LJ, Morales JA, Bitzer-Quintero OK. From probiotics to psychobiotics: live beneficial bacteria which act on the brain-gut axis. Nutrients. 2019;11(4):890. doi:10.3390/Nu11040890
   PubMed Web of Science ®Google Scholar
• Lew L-C, Hor -Y-Y, Yusoff NAA, et al. Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: a randomised, double-blind, placebo-controlled study. Clin. Nutr. 2019;38(5):2053–2064. doi:10.1016/j.clnu.2018.09.010
   PubMed Web of Science ®Google Scholar
• Ruiz-Gonzalez C, Roman P, Rueda-Ruzafa L, Rodriguez-Arrastia M, Cardona D. Effects of probiotics supplementation on dementia and cognitive impairment: a systematic review and meta-analysis of preclinical and clinical studies. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2021;108:110189. doi:10.1016/j.pnpbp.2020.110189
   PubMed Web of Science ®Google Scholar
• Toral M, Romero M, Rodríguez-Nogales A, et al. Lactobacillus fermentum improves tacrolimus-induced hypertension by restoring vascular redox state and improving eNOS coupling. Mol. Nutr. Food Res. 2018;62(14):1800033. doi:10.1002/mnfr.201800033
   Web of Science ®Google Scholar
• Toral M, Gómez-Guzmán M, Jiménez R, et al. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin. Sci. 2014;127(1):33–45. doi:10.1042/cs20130339
   Web of Science ®Google Scholar
• Mogotsi MT, Mwangi PN, Bester PA, et al. Metagenomic analysis of the enteric RNA virome of infants from the Oukasie clinic, North West province, South Africa, reveals diverse eukaryotic viruses. Viruses. 2020;12(11):1260. doi:10.3390/v12111260
   PubMed Web of Science ®Google Scholar
• Gregory AC, Zablocki O, Zayed AA, Howell A, Bolduc B, Sullivan MB. The gut virome database reveals age-dependent patterns of virome diversity in the human gut. Cell Host Microbe. 2020;28(5):724–740. doi:10.1016/j.chom.2020.08.003
   PubMed Web of Science ®Google Scholar
• Hidalgo-Cantabrana C, Sanozky-Dawes R, Barrangou R. Insights into the human virome using CRISPR spacers from microbiomes. Viruses. 2018;10(9):479. doi:10.3390/v10090479
   PubMed Web of Science ®Google Scholar
• Burmistrz M, Krakowski K, Krawczyk-Balska A. RNA-targeting CRISPR–Cas systems and their applications. Int J Mol Sci. 2020;21(3):1122. doi:10.3390/ijms21031122
   PubMed Web of Science ®Google Scholar
• Toyofuku M, Nomura N, Eberl L. Types and origins of bacterial membrane vesicles. Nature Reviews Microbiology. 2018;17(1):13–24. doi:10.1038/s41579-018-0112-2
   Web of Science ®Google Scholar
• Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478):eaau6977. doi:10.1126/science.aau6977
   PubMed Web of Science ®Google Scholar
• Macia L, Nanan R, Hosseini-Beheshti E, Grau GE. Host- and microbiota-derived extracellular vesicles, immune function, and disease development. Int J Mol Sci. 2019;21(1):107. doi:10.3390/ijms21010107
   PubMed Web of Science ®Google Scholar
• Zhang Y, Bi J, Huang J, Tang Y, Du S, Li P. Exosome: a review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomedicine. 2020;15:6917–6934. doi:10.2147/ijn.s264498
   PubMed Web of Science ®Google Scholar
• Taghinezhad SS, Mohseni AH, Bermudez-Humaran LG, et al. Probiotic-based vaccines may provide effective protection against COVID-19 acute respiratory disease. Vaccines (Basel). 2021;9(5):466. doi:10.3390/vaccines9050466
   PubMed Web of Science ®Google Scholar
• Dyakov IN, Mavletova DA, Chernyshova IN, et al. FN3 protein fragment containing two type III fibronectin domains from B. longum GT15 binds to human tumor necrosis factor alpha in vitro. Anaerobe. 2020;65:102247. doi:10.1016/j.anaerobe.2020.102247
   PubMed Web of Science ®Google Scholar
• Veselovsky VA, Dyachkova MS, Menyaylo EA, et al. Gene networks underlying the resistance of Bifidobacterium longum to inflammatory factors. Front Immunol. 2020;11:595877. doi:10.3389/fimmu.2020.595877
   PubMed Web of Science ®Google Scholar
• Hmood KA, Habeeb AH, Al-Mhnna KI. Antioxidant role of Lactobacillus sp isolated from honey bee against histological effects of ochratoxin in vivo. Al-Kufa University Journal for Biology. 2019;11(2):67–80.
   Google Scholar
• Kešnerová L, Emery O, Troilo M, Liberti J, Erkosar B, Engel P. Gut microbiota structure differs between honeybees in winter and summer. ISME J. 2020;14(3):801–814. doi:10.1038/s41396-019-0568-8
   PubMed Web of Science ®Google Scholar
• Ignasiak K, Maxwell A. Antibiotic-resistant bacteria in the guts of insects feeding on plants: prospects for discovering plant-derived antibiotics. BMC Microbiol. 2017;17(1):223. doi:10.1186/s12866-017-1133-0
   PubMedGoogle Scholar
• Ellegaard KM, Engel P. Genomic diversity landscape of the honey bee gut microbiota. Nature Communications. 2019;10(1):446. doi:10.1038/s41467-019-08303-0
   PubMedGoogle Scholar
• Iorizzo M, Testa B, Ganassi S, et al. Probiotic properties and potentiality of Lactiplantibacillus plantarum strains for the biological control of chalkbrood disease. Journal of Fungi. 2021;7(5):379. doi:10.3390/jof7050379
   Web of Science ®Google Scholar
• Pan D, Mei X. Antioxidant activity of an exopolysaccharide purified from Lactococcus lactis subsp. lactis 12. Carbohydr. Polym. 2010;80(3):908–914. doi:10.1016/j.carbpol.2010.01.005
   Web of Science ®Google Scholar
• D’Alvise P, Böhme F, Codrea MC, et al. The impact of winter feed type on intestinal microbiota and parasites in honey bees. Apidologie. 2017;49(2):252–264. doi:10.1007/s13592-017-0551-1
   Web of Science ®Google Scholar
• Wang X, Zhong Z, Chen X, et al. High-fat diets with differential fatty acids induce obesity and perturb gut microbiota in honey bee. Int J Mol Sci. 2021;22(2):834. doi:10.3390/ijms22020834
   PubMed Web of Science ®Google Scholar
• Honey Chandran C, Keerthi TR. Probiotic potency of Lactobacillus plantarum KX519413 and KX519414 isolated from honey bee gut. FEMS Microbiol Lett. 2018;4(365):1–8. doi:10.1093/femsle/fnx285
   Google Scholar
• Kenfack HMC, Ngoufack ZF, Kaktcham MP, Wang RY, Zhu T, Yin L. Safety and antioxidant properties of five probiotic Lactobacillus plantarum strains isolated from the digestive tract of honey bees. American Journal of Microbiological Research. 2018;6(1):1–8. doi:10.12691/ajmr-6-1-1
   Google Scholar
• Niode N, Salaki C, Rumokoy L, Tallei T Lactic acid bacteria from honey bees digestive tract and their potential as probiotics. In: Buchori D, ed. International Conference and the 10th Congress of the Entomological Society of Indonesia. Series Advances in Biological Sciences Research. 8. Indonesia: Atlantis Press SARL; 2020:236–241.
   Google Scholar
• Todorov SD, Tagg JR, Ivanova IV. Could Probiotics and Postbiotics Function as “Silver Bullet” in the Post-COVID-19 Era? Probiotics and Antimicrobial Proteins. 2021;1:1–9. doi:10.1007/s12602-021-09833-0
   Google Scholar
• Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat. Rev. Gastroenterol. Hepatol. 2021;18(9):649–667. doi:10.1038/s41575-021-00440-6
   PubMed Web of Science ®Google Scholar
• Xu C, Qiao L, Guo Y, Ma L, Cheng Y. Preparation, characteristics and antioxidant activity of polysaccharides and proteins-capped selenium nanoparticles synthesized by Lactobacillus casei ATCC 393. Carbohydr. Polym. 2018;195:576–585. doi:10.1016/j.carbpol.2018.04.110
   PubMed Web of Science ®Google Scholar
• Molina-Tijeras JA, Galvez J, Rodriguez-Cabezas ME. The Immunomodulatory Properties of Extracellular Vesicles Derived from Probiotics: a Novel Approach for the Management of Gastrointestinal Diseases. Nutrients. 2019;11(5):1038. doi:10.3390/nu11051038
   PubMed Web of Science ®Google Scholar
• Nishiyama K, Takaki T, Sugiyama M, et al. Extracellular Vesicles Produced by Bifidobacterium longum Export Mucin-Binding Proteins. Appl Environ Microbiol. 2020;86(19):e01464–01420. doi:10.1128/AEM.01464-20
   PubMed Web of Science ®Google Scholar
• Dixit Y, Wagle A, Vakil B. Patents in the Field of Probiotics, Prebiotics, Synbiotics: a Review., 01(02). Journal of Food: Microbiology, Safety & Hygiene. 2016;01(02):1000111. doi:10.4172/2476-2059.1000111
   Google Scholar
• Rani A, Saini KC, Bast F, et al. Microorganisms: a Potential Source of Bioactive Molecules for Antioxidant Applications. Molecules. 2021;26(4):1142. doi:10.3390/molecules26041142
   PubMed Web of Science ®Google Scholar
• Sleator RD, Hill C. Engineered pharmabiotics with improved therapeutic potential. Human vaccines. 2008;4(4):271–274. doi:10.4161/hv.4.4.6315
   PubMedGoogle Scholar
• Sleator RD, Hill C. Rational design of improved pharmabiotics. J Biomed Biotechnol. 2009;2009:275287. doi:10.1155/2009/275287
   PubMedGoogle Scholar
• Shanahan F, Collins SM. Pharmabiotic manipulation of the microbiota in gastrointestinal disorders, from rationale to reality. Gastroenterol Clin North Am. 2010;39(3):721–726. doi:10.1016/j.gtc.2010.08.006
   PubMed Web of Science ®Google Scholar
• Maria Remes Troche J, Coss Adame E, Angel Valdovinos Diaz M, et al. Lactobacillus acidophilus LB: a useful pharmabiotic for the treatment of digestive disorders. Therap Adv Gastroenterol. 2020;13:1756284820971201. doi:10.1177/1756284820971201
   Web of Science ®Google Scholar